Hospital innovation programs

The AdventHealth Nicholson Center is a 54,000-square-foot medical learning and simulation incubation center in Celebration, Florida, which AdventHealth describes as one of the nation's largest and most experienced facilities of its kind. It trains physicians and surgical teams in clinical and surgical techniques using 50 surgical and clinical skills stations covering da Vinci robotic, laparoscopic, open and orthopedic procedures, plus two team-training operating rooms built to simulate real operating environments. It also has a 500-seat conference auditorium with HD multimedia and a 16-TV customizable video wall for large courses and product launches. The center explicitly leverages relationships with industry and academia to deliver its education, and medical device and surgical robotics companies use it to develop, validate and launch training programs for new systems in the United States. Outside companies engage the center as sponsors of training programs, research collaborators and users of its labs and simulation infrastructure.

Advocate Health's enterprise innovation function is led by a Chief Innovation and Commercialization Officer and combines an external-partnership front door with an internal commercialization office. Its Innovative Collaborations track acts as a catalyst between outside organizations and Advocate Health's strategic priorities, with an online form and a shared inbox as the entry point for companies proposing partnerships. The Technology Transfer Office converts internal ideas and research into commercial products, providing intellectual property evaluation and protection, market analysis, funding support and startup creation. The function also stewards Advocate Health's innovation places, including The Pearl in Charlotte, the Innovation Quarter in Winston-Salem and IRCAD North America. It serves clinicians and researchers across the merged Advocate Aurora and Atrium Health footprint and is distinct from Advocate Aurora Enterprises.

The Advocate Health Technology Transfer Office converts research and novel concepts generated inside the system into practical products. It handles intellectual property protection, market analysis, funding support and startup creation for clinician and researcher inventors across Advocate Health. It sits alongside the system's other innovation channels, including an Innovative Collaborations function that connects external organizations to Advocate Health's strategic priorities through an idea submission form, and physical innovation districts at The Pearl in Charlotte and Innovation Quarter in Winston-Salem. Outside companies engage through the collaboration submission process and through the innovation districts, which host startups and established biomedical, digital health and regenerative medicine companies. General innovation inquiries route to a single system mailbox.

The Pearl is Advocate Health and Atrium Health's innovation district in Charlotte's historic Brooklyn neighborhood, launched June 2, 2025 in partnership with Wexford Science & Technology and Ventas. It is designed as a physical ecosystem that co-locates medical education, research, industry partners and health technology companies so that surgeons, scientists, startups and students work in proximity. Its anchors are the Wake Forest University School of Medicine Charlotte campus, Charlotte's first four-year medical school, and IRCAD North America, the exclusive North American headquarters of the advanced surgical training institute. Siemens Healthineers operates a U.S. Experience Center in the district. Outside companies engage The Pearl as tenants, training partners and research collaborators rather than through an investment vehicle.

Advocate Aurora Enterprises was the investment and business-building arm of Advocate Aurora Health, now part of Advocate Health, the third-largest nonprofit health system in the country. Rather than making only minority venture investments, it acquired and operated consumer health and wellness businesses outright across three declared platforms: aging independently, parenthood and personal performance. It also led and participated in digital health venture rounds alongside other systems. Its highest-profile acquisition was Senior Helpers, a national non-clinical home care franchise operating in 44 states, Canada and Australia, bought in April 2021. Advocate sold Senior Helpers to private equity firm Waud Capital Partners in March 2024, less than three years after the purchase, marking a significant retrenchment of the platform strategy.

The Center for Healthcare Innovation is the implementation-focused innovation engine inside Atrium Health Wake Forest Baptist, built around the premise that it takes an average of 17 years to move medical discoveries into mainstream care and that the gap can be narrowed. Rather than waiting for conventional commercialization, CHI takes published research findings, practices and products directly into clinical settings, and evaluates novel ideas that make clinicians more efficient. It runs LAUNCH, an annual innovation incubator, competition and accelerator whose winners receive funding, with past winners working on dementia care, blood pressure management, cognitive health and fall prevention. Its active project portfolio includes D-Care for dementia care, HN-STAR for head and neck cancer survivors, IGLOO for blood pressure management, mPATH, MindCare365 and PATINA+. It offers membership to Advocate Health and Wake Forest University-affiliated researchers and collaboration partnerships to external organizations, and works alongside Wake Forest Innovations and the Wake Forest Clinical and Translational Science Institute.

The Office of Translational Research, Innovation, and Technology Transfer supports Albany Medical College inventors in moving biomedical discoveries toward commercialization. It provides intellectual property protection, licensing support, commercialization guidance and prototyping assistance, manages the institution's IP portfolio, and connects inventors with accelerators, funders and regional partners across New York's Capital Region. The office runs the Capital Region Bioinnovation Bootcamp, a co-hosted educational program covering IP, FDA regulation, funding and market strategy that ends in a pitch competition, and a Clinical Immersion Program in which students shadow clinicians to identify innovation opportunities that are developed into proof-of-concept ventures. It also hosts the annual Capital Region Bioinnovation Forum and internal seminars. Companies engage by licensing technologies from the office's portfolio, which spans biological agents, medical methods, medical technologies, research tools and vaccine platforms; inventors receive 40 percent of royalties from commercialized technologies.

AlphaLab Health is a healthcare and life sciences startup accelerator launched in 2020 as a partnership between Allegheny Health Network, Highmark Health and Innovation Works, with support from Pittsburgh-area universities, corporations and foundations. It follows Innovation Works' accelerator model, providing seed funding, mentorship, clinical resources and workspace to early-stage companies in diagnostics, therapeutics, health IT, medical devices and packaging. Participating startups receive up to $100,000 in seed investment plus access to AHN researchers and clinicians, industry leaders, early customers, potential investors and mentors. The program operates from a 10,000-square-foot facility with wet and dry labs, dedicated offices, conference rooms and collaboration space at the former Allegheny General Hospital Suburban campus in Bellevue, Pennsylvania. It is distinct from Highmark Ventures, the system's separate investment arm.

Innovate2Impact is the innovation and intellectual property program of Lurie Children's and the Stanley Manne Children's Research Institute, created to bridge the gap between discovery and usable products and technologies. It supports clinicians and scientists across Lurie Children's laboratories, clinics and community programs with invention disclosure, IP protection and technology licensing. The program operates in partnership with Northwestern University's Innovation and New Ventures Office (INVO), sharing a web-enabled invention disclosure portal and licensing infrastructure. Companies engage it through a public technology portal that lists available Lurie Children's innovations, and the team includes staff dedicated to innovation portfolio management and industry engagement.

Ascension Ventures is the strategic healthcare venture capital arm founded by the Catholic health system Ascension in 2001, and is one of the oldest continuously operating provider-sponsored funds in the United States. It invests across healthcare information technology, healthcare services, medical devices and diagnostics, and describes itself as stage-agnostic while favoring companies within three to five years of a potential exit. Typical checks run $10 million to $20 million per company, and the firm generally requests a board seat or observation rights. Unusually for a corporate venture arm, it raises multi-system funds: its limited partner base includes a dozen other large health systems that together operate roughly 300 acute care hospitals. It invests only; it does not operate as a company-building studio.

The Clinical Innovation Institute is Ascension's clinician-led unit for vetting and deploying new technology across the system's multi-state footprint. Launched in August 2025, it brings together a multidisciplinary team to evaluate technologies that streamline clinician workflows, reduce administrative burden and improve the patient and caregiver experience. The institute is directed jointly by four Ascension executives spanning clinical transformation, medical informatics, academics and clinical innovation. It also works to expand access to clinical trials for Ascension patients and to apply clinical data insights to care redesign. Outside companies engage it as the front door for having a solution assessed and, if validated, implemented across Ascension sites; it is distinct from Ascension Ventures, the system's separate venture capital arm.

Banner Health formed the Banner Innovation Group in 2019 to centralize its innovation efforts, staffing it with roughly 15 people drawn from healthcare, retail, startups, private equity and design and housing it in two offsite open-concept workspaces. Its venture function targets early-stage private companies with customer-centric solutions that improve patient outcomes, address clinical and operational challenges, and create new models of access. Banner engages through direct investments, limited partnership commitments to venture funds, collaborative development and licensing agreements. The group also funds internal inventors and pilots employee and clinician ideas across the system's Arizona-anchored footprint. It both invests externally and cultivates internal innovation.

The Baptist Health Innovation Fellowship is a yearlong program created to attract, train and empower healthcare visionaries and entrepreneurs across South Florida, including Baptist Health physicians and clinicians. Fellows attend ten Friday sessions from September to June covering intellectual property, the regulatory environment, investment capital, product development and core innovation skills. They work in multidisciplinary teams to identify unmet healthcare needs and develop candidate solutions, culminating in presentations to investors and health system executives. Graduates join an ongoing community of innovators and remain eligible for Baptist Health's other innovation challenge programs. The fellowship was launched with support from the John S. and James L. Knight Foundation and requires applicants to live in Miami-Dade, Broward, Palm Beach or Monroe County.

The Baylor Licensing Group is the technology commercialization office of Baylor College of Medicine, operating within the Office of Research. Its stated purpose is to maximize the impact of Baylor research through commercial relationships that lead to new products and services benefiting patients and the public. The group works with faculty to evaluate invention disclosures and identify the appropriate pathway to market, whether licensing to an established company or forming a startup. It manages Baylor's patent portfolio and negotiates license agreements with industry partners.

The Technology Transfer Office is the commercialization unit of Baylor Scott & White Research Institute, charged with translating ideas and research from BSWRI and Baylor Scott & White Health staff into inventions and discoveries that reach the public. It handles intellectual property evaluation, protection and licensing, and coordinates prototype development and proof-of-concept work for inventors. It also runs technology transfer training for inventors and industry partners and manages consulting agreements between industry and BSWH staff. Its licensing portfolio concentrates on immunotherapies, vaccines, biomarkers, targeting antibodies and medical devices, with prior patents covering treatments for systemic onset juvenile idiopathic arthritis and cancer therapies. Outside companies engage the office directly through its inventions inbox for licensing and business development, supported by BSWRI's regulatory, compliance and conflict-of-interest structures.

The Technology Transfer Office is the commercialization unit of Baylor Scott & White Research Institute, working to translate research conducted across Baylor Scott & White Health into inventions that reach patients. It evaluates, patents, markets and licenses technologies developed by BSWRI researchers as well as those arising from third-party collaborations. The office supports inventors with researcher networking, confidentiality and collaboration agreements, prototype development, intellectual property management and business transaction facilitation. Outside companies engage through licensing of available technologies and through sponsored collaboration agreements negotiated by the office. Its current licensable portfolio spans immunotherapies, vaccines, biomarkers, targeting antibodies and medical devices.

TechSpring is Baystate Health's technology innovation center, founded in 2014 in Springfield, Massachusetts, and positioned at the intersection of healthcare delivery and innovative technology. Its model is to connect clinicians who understand care delivery problems with technology innovators who can build solutions, giving startups access to real clinical validation. TechSpring runs four program tracks: Insights, in which clinicians and patients give structured feedback to startups; Projects, in which startups work with innovation partners to validate solutions; Analytics, in which startups execute projects using Baystate Health data; and Interfaces, which builds digital health infrastructure with technology partners. It serves early-stage digital health companies as well as Baystate clinicians and staff who submit needs and ideas. Outside companies engage as sponsors, innovation partners and startup participants in these tracks.

The Health Technology and Exploration Center is Beth Israel Deaconess Medical Center's center for evaluating and developing emerging healthcare technologies. It rapidly evaluates and develops high-risk, high-reward technologies to advance both BIDMC's own capabilities and those of partner organizations internationally. The center works through formalized affiliations and partnerships that extend BIDMC's health IT and informatics expertise to other institutions. Its focus areas include patient engagement, continuity of care, precision medicine and access to care, with the goal of building scalable technologies that make care more accessible, efficient and integrated. It is led from BIDMC's information systems organization and describes itself as the first center of its kind at a Harvard teaching hospital.

The Technology Ventures Office is the intellectual property and commercialization office for Beth Israel Deaconess Medical Center, part of Beth Israel Lahey Health. It promotes commercialization of BIDMC innovations by working with biomedical companies, venture capitalists and entrepreneurs to find the best route to market for each technology. Core functions include negotiating research and license agreements, managing patent prosecution, sourcing industry-sponsored research funding, facilitating startup formation, guiding investigators along commercialization pathways and distributing royalty income to inventors. The office serves BIDMC faculty, clinicians and researchers across the medical center's research enterprise. Outside companies engage through licensing, sponsored research and industry partnership agreements negotiated by the TVO's licensing and legal staff.

The Healthcare Innovation Lab is a joint BJC HealthCare and Washington University School of Medicine unit, housed within BJC's Center for Clinical Excellence, that develops and tests new care delivery models rather than commercializing intellectual property. It defines innovation as a new idea that creates value when implemented, and uses agile, human-centered design plus rigorous evaluation to move ideas from concept to deployed practice. Work is organized around predictive analytics, digital care tools for clinics and hospitals, and remote patient monitoring for high-risk patients at home, delivered through program tracks including Big Ideas, Strategic Innovation, an Innovation Trainee fellowship for residents and fellows, and Epic predictive analytics. It partners with outside vendors and technology companies to pilot tools inside BJC's clinical operations.

Accrete Health Partners is the venture and innovation platform of Bon Secours Mercy Health, one of the largest Catholic health systems in the United States. It describes its mandate as building a digital health ecosystem that aligns and unifies digital health teams, products and services rather than simply writing checks. In addition to direct venture investments, it runs Accrete Acceleration, a company-building and scaling function, and it has taken ownership and control positions in operating businesses. The team is led by a dedicated president with separate digital ventures and clinical digital ventures leadership. Bon Secours Mercy Health has been repeatedly cited as one of the most active provider investors in digital health.

Bon Secours Mercy Health's Mercy Health innovation team in its Northern Region runs an entrepreneurship and idea-commercialization program built around a Director of Innovation, an Entrepreneur in Residence, a Business Advisor for underserved entrepreneurs and an Innovation Grant Manager. Internally it holds annual Innovation Challenges at its Toledo hospitals, where associates submit ideas to improve patient care, and convenes clinician ideation sessions on specific problems. Externally it serves community entrepreneurs through "Getting Your Business Started," a free eight-week entrepreneurship class funded by the PNC Foundation that awards laptops to participants. The team draws on state and federal economic development programs including Ohio Third Frontier's Entrepreneurial Services Program and Technology Validation Start-up Fund and the SBA Community Navigator Program. This program is separate from the system's venture arm, Accrete Health Partners (formerly Accel Health).

The Innovation & Digital Health Accelerator is Boston Children's Hospital's internal startup accelerator, created to source and vet ideas from the hospital's own clinicians and to build them into products and companies. IDHA runs an internal funding and vetting process, then supplies grant funding, product management oversight and technical expertise across mobile and web applications, medical devices, telemedicine and EHR interoperability using FHIR standards. Its priorities include expanding remote care access, building clinical decision support tools that extend Boston Children's pediatric expertise globally, and creating scalable interoperable digital health platforms. The accelerator is co-led by the hospital's Chief Innovation Officer and Vice President for Digital Health and has been profiled in Harvard Business Review as a model for helping doctors launch companies.

Boston Children's Hospital publishes two complementary innovation functions. The Technology and Innovation Development Office states that its mission is to maximize the impact of Boston Children's innovations on patient health while enhancing the research endeavor. Official TIDO pages say the office manages all intellectual property arising from the hospital, supports technology development through the Therapeutic and Medical Device Accelerator, establishes research and development partnerships, and negotiates license and research agreements. Irene Abrams is publicly identified as Vice President for Technology Development and New Ventures and head of TIDO. A May 2025 hospital announcement stated that the Therapeutic and Medical Device Accelerator had named inaugural internal-funding awardees under Senior Director Nadine Beauger, PhD, MBA. Separately, the Innovation and Digital Health Accelerator describes work to build digital health products, collaborate with industry, and deploy digital tools. Official IDHA materials identify John Brownstein, PhD, as Chief Innovation Officer and Jen Magaziner as Vice President for Digital Health and co-lead of IDHA. This profile reports both official structures and does not collapse them into a single ranking or performance claim.

The Center for Digital Health, launched in 2020 as the joint Brown-Lifespan Center for Digital Health, is a research and innovation hub spanning Brown University and Brown University Health, formerly Lifespan. Its mission is to advance interdisciplinary research and innovation that develops, evaluates and translates digital health technologies to improve health outcomes, care delivery and health equity. The center brings together researchers, clinicians, engineers, students and industry partners, with expertise spanning medicine, public health, computer science and engineering. It operates a Digital Health Innovation Sandbox, a prototyping environment for developing and validating emerging digital health technologies, and it trains future digital health professionals. Outside companies engage as industry partners and through research collaborations, such as a partnership with Etiometry on adult critical care.

The Geri and Richard Brawerman Nursing Institute is Cedars-Sinai's home for nursing research, education and innovation, reflecting a renewed institutional focus on nurse-generated science and practice change. Its Nursing Research and Innovation function supports Cedars-Sinai nurses across study design, data management, dissemination and funding so that clinical nurses can lead research that improves patient outcomes. The institute is directed by an executive director who also holds an endowed chair specifically titled for nurse education, innovation and research. The institute has developed an advanced leadership fellowship to move nurses into prominent healthcare and policy roles, and runs a Nursing Innovation Forum, an accredited half-day program on how nurses can use artificial intelligence, creativity and leadership to drive organizational transformation. The forum draws faculty from other health systems including Mount Sinai and UnityPoint Health.

Cedars-Sinai Technology Ventures is the health system's publicly described home for intellectual property, venture investment, and startup acceleration. A Cedars-Sinai newsroom article states that Technology Ventures is led by James D. Laur, JD, chief intellectual property officer, and Nirdesh K. Gupta, PhD, managing director. That article reports a portfolio of more than 500 technologies, more than 1,100 patents, and more than $1 billion in technology transfer revenue over the prior five years. The Cedars-Sinai Accelerator, later presented as Accelerator+, is described on official program pages as a Los Angeles-based program created to help entrepreneurs bring healthcare technology products to market. Early program materials described a three-month program with $100,000 in funding and mentorship from more than 300 clinicians and executives, beginning in 2016. Current Accelerator+ materials describe a longer venture-building platform for seed-stage healthcare companies that includes capital, clinical and market expertise, and evaluation inside the Cedars-Sinai Health System. This profile reports those official statements and does not treat revenue or patent counts as a ranking.

The Pediatric Technology Center (PTC) is a joint center of Children's Healthcare of Atlanta and Georgia Tech that pairs pediatric clinicians from Children's with Georgia Tech scientists and engineers to build technological solutions to problems in children's health. It exists because most medical device and technology development is designed for adults, and the center positions itself as addressing that gap for pediatric populations. Work is organized into research pillars covering data science, machine learning and AI for personalized pediatric care; patient-centered care delivery spanning behavioral health, rural access and whole-child care; and technologies and devices adapted for children. The center is housed on the ground floor of the Krone Engineered Biosystems Building on the Georgia Tech campus and draws on a Children's-Georgia Tech collaboration spanning more than two decades. It engages outside parties through faculty research collaborations, seed research grants to joint clinician-engineer teams, and pathways to bring new clinical processes and devices to market.

The Patient Care Services Research Fellowship is an 18-month hospital-based fellowship run by the Patient Care Services research team at Children's Hospital Colorado in partnership with the University of Colorado College of Nursing. Fellows combine didactic instruction with a mentored research experience: they develop their own research question with a faculty nurse scientist mentor, pursue funding and IRB approval, complete the study and publish the findings. The broader program also provides nurse-scientist mentorship on project design, literature review, statistical consultation and dissemination, plus workshops on research principles, evidence-based practice and quality improvement. The team engages externally through the National Pediatric Nurse Scientist Collaborative, which runs monthly calls and an annual conference for pediatric nurse scientists. Inquiries are handled through a dedicated nursing research mailbox.

The Center for Innovation, established in 2016, is Children's Hospital Colorado's hub for education, incubation and acceleration of pediatric healthcare ideas from its faculty and staff. It supports development of new drugs, medical devices, diagnostics and digital health technologies, and gives internal innovators access to a network of entrepreneurs-in-residence, mentors and innovation managers drawn from serial entrepreneurs, technical experts and venture capitalists. Its stated goals include stimulating innovation, launching ventures, bringing outside technology into clinical care and attracting top faculty and students. Outside companies engage through a partner submission form and can collaborate in three defined ways: ideation expertise on clinical problems, testing and clinical validation using the hospital as a healthcare testbed, and clinical expertise on workflows. Faculty and staff submit ideas through a separate internal form, and the center takes meeting requests by email.

The CHLA Innovation Studio incubates and accelerates processes and technologies that solve complex problems in pediatric health care, working across four pillars: care model innovation, technology advancement, idea incubation and digital health equity. It uses human-centered design to surface care delivery problems and build solutions, and operates a Digital Health Lab that develops digital therapeutics, clinical education tools and patient and provider experience technology. Programs include Connected Care telehealth and online second opinions, a mental well-being initiative for teens, and patient-centered diabetes care redesign. Outside companies engage principally through KidsX.Health, the CHLA-founded consortium and accelerator that pairs digital health startups with pediatric hospitals, and through the West Coast Consortium for Technology and Innovation in Pediatrics. The studio serves CHLA clinicians and staff as well as external startups and partner children's hospitals.

KidsX is a pediatric digital health accelerator and hospital consortium founded and administered by Children's Hospital Los Angeles. It anchors a global ecosystem of children's hospitals that want to accelerate health innovation and transform pediatric care, and it runs accelerators, innovation challenges and consortium initiatives. The accelerator uses a reverse-pitch model in which member hospitals define their needs at the start of the program so participating companies align their products to real pediatric demand from day one. Outside digital health companies apply to cohorts and are matched with member hospitals for pilots; hospitals join by contacting the CHLA-based consortium team. Recent cohort priorities include AI automation for workforce optimization, care journey navigation, health literacy tools, hospital-at-home technologies and pediatric mental and behavioral health.

CTIP is an FDA-funded pediatric device consortium led by Children's Hospital Los Angeles that accelerates the development and commercialization of pediatric medical devices from concept to market. It offers innovators networking, direct and indirect financial support through seed grants, and guidance on intellectual property, prototyping, engineering, testing, grant writing and clinical trial design. The consortium serves academic inventors, clinicians and outside medical device startups across California, Oregon and Washington, and is one of a small number of pediatric device consortia funded nationally by the FDA. Its network includes UCLA, Oregon Health & Science University, USC, UC San Diego, UC Berkeley and Seattle Children's Hospital. Companies engage by applying for seed funding and advisory support rather than by giving up equity.

Mi4 is CHOC's institute-level innovation hub, created to accelerate innovation and insight that advances children's health through new diagnostic, treatment and care solutions. It concentrates on emerging technology domains including artificial intelligence, genomic medicine, regenerative medicine, robotics and nanomedicine, pairing clinicians with technologists. The institute runs a competitive summer internship program supported by more than 50 expert mentors, holds monthly innovation meetings open to the CHOC community, and hosts an annual Innovation Day. It engages outside organizations through affiliated bodies it helped create, including AIMed, the Medical Intelligence Society and the International Society of Pediatric Innovation, which bring industry, academic and startup participants into CHOC's pediatric innovation network. It was endowed by a gift from the Sharon D. Lund Foundation.

Children's Hospital of Philadelphia publishes a pediatric commercialization pathway that has been reorganized over the past decade. In 2015, CHOP created the Office of Entrepreneurship and Innovation to identify, evaluate, and develop digital, diagnostic, device, and therapeutic assets and to provide strategy, acceleration support, and investment capital toward a commercial exit or new-company formation. The CHOP Research Institute now presents Innovation Ventures as the primary gateway for researchers seeking to commercialize discoveries. Official pages state that Innovation Ventures is a team of licensing, business development, contracting, and investment professionals, and that the offices of Technology Transfer, Collaborative and Corporate Research Contracts, and the Innovation Ecosystem act as a one-stop shop for translation, development, and licensing. Becker's Healthcare reported in 2026 that Tom Wilton joined CHOP in 2025 as Senior Vice President of Innovation Ventures. This profile records the publicly described structure and leadership transition. It does not rank CHOP against other children's hospitals or infer commercial results that are not stated by an official source.

The Center for Pediatric Innovation turns discoveries and clinical ideas from Children's Mercy staff into marketable pediatric products and services. It runs a three-phase process of need validation, solution validation and market validation, with in-house expertise in product development, software, intellectual property and go-to-market strategy. The center serves clinicians, nurses and staff across the hospital through programs such as the annual SPARK Employee Innovation Bash pitch competition, and it commercializes finished products through PedsMarket, its own online marketplace for pediatric innovations. It also partners with startups, entrepreneurs and established companies on co-development and commercialization of pediatric solutions.

Innovation Ventures is the innovation and technology transfer office of Children's National Hospital in Washington, DC, operating within the hospital's Research and Innovation Campus. It manages all aspects of intellectual property development arising from the pediatric hospital's clinicians and researchers, including patents, copyrights, research tools, software and know-how. The office markets, licenses and commercializes those assets and builds strategic business partnerships with industry. It also supports startup formation around pediatric device and digital health inventions and negotiates collaboration agreements with medical technology companies. It is a commercialization and partnering organization rather than an external venture fund.

Children's National's Innovation Ventures office manages all aspects of intellectual property development for Children's National Hospital and the Children's National Research Institute. It creates strategic business partnerships with external stakeholders and provides educational programming to foster academic entrepreneurship among pediatric clinicians and scientists. The office handles protection, marketing, licensing and commercialization of patents, copyrights, research tools, software and know-how. It maintains a public portal of available pediatric technologies for licensing.

ChristianaCare's Health & Technology Innovation Center is the system's innovation unit, led by a vice president of innovation, and its flagship program is the biennial ChristianaCare Innovation Challenge, established in 2016. Caregivers across the system submit ideas for new technology, apps or care innovations over the summer, and judges score them on potential impact, viability and alignment with ChristianaCare's aspirations to end disparities, simplify access and keep people healthy at home. Four finalists deliver 15-minute pitches at the Innovation Summit finale, a two-day conference held at ChristianaCare's Newark, Delaware campus. Winners receive development support from the Innovation Center team to bring their ideas to fruition rather than a cash prize alone. The center is separate from ChristianaCare's Nursing Research Fellowship in Robotics and Innovation and works closely with the system's chief digital and information officer.

ChristianaCare's Nursing Research Fellowship in Robotics and Innovation is an eight-month program that puts bedside nurses in the lead on research and development involving collaborative robotics. Fellows study how robots can absorb operational tasks such as supply delivery and lab specimen runs so nurses can spend more time on direct patient care. The fellowship was created by ChristianaCare's Director of Technology Research and Education and is funded by a grant from the American Nurses Foundation's Reimagining Nursing Initiative. Fellows carry their learning back into the organization, and the inaugural cohort's work reached hundreds of ChristianaCare nurses. ChristianaCare has also placed nurse leaders as fellows in national nursing innovation fellowship programs.

Cincinnati Children's Innovation Ventures is a named pediatric health-system program for translating research and ideas into products, services, and companies. The official Innovation Ventures page says the program pursues licensing, startups, collaborative and sponsored research, solutions to high-value clinical needs, and piloting or co-developing external opportunities. Its technology-transfer and commercialization page describes guidance for innovators, connections to funding opportunities and tools, and commercial-development funding for Cincinnati Children's employees advancing technologies with commercial potential and viability. The official technology portfolio provides a public route for exploring licensing opportunities across diagnostics, educational and consumer products, medical devices, research tools, software, and therapeutics. This profile records the program's stated routes and categories without inferring the activity, ownership, value, or performance of any particular technology or company.

City of Hope's Office of Technology Licensing works with City of Hope inventors to identify, protect and commercialize their inventions and technologies. It develops intellectual property protection through patents, trademarks and copyrights, identifies strategic partnerships and licensing opportunities, and negotiates license agreements with commercial partners. OTL also supports inventor-led startups by connecting them with investor relationships. The office manages material transfer agreements, confidential disclosure agreements and research collaboration agreements.

Cleveland Clinic Innovations is the health system's commercialization function for inventions that originate with Cleveland Clinic clinicians and researchers. Official program materials describe a model that evaluates inventions, matches opportunities to licensing, development, or company-creation pathways, and works with industry partners. In a 2025 year-in-review, the program stated that it has operated for 25 years and has expanded beyond a historically medical-device-centered portfolio into digital health, therapeutics, diagnostics, and operational technologies. D. Geoffrey Vince, PhD, is publicly identified as Chief of Innovations and Chair of Biomedical Engineering. Public materials describe an investments and ventures function, business development and licensing leadership, and a team that reviews inventions, manages intellectual property, and supports company formation. This profile reports only what official Cleveland Clinic pages and related public leadership biographies confirm. It does not assess commercial performance or compare Cleveland Clinic against other systems.

Cleveland Clinic's system-wide Office of Nursing Research and Innovation supports nurses who want to pursue research questions or develop innovative processes, systems and devices, on the premise that the most important ideas come from clinicians providing direct patient care. The office staffs PhD-prepared nurse scientists who mentor bedside nurses through study design, evidence-based practice projects and dissemination. It added a dedicated innovation coordinator role to guide nurses through idea development, and works with the Cleveland Clinic Innovations team for prototyping support and commercialization guidance. The office also runs an evidence-based practice eLearning course and a three-year distance-mediated Post-Doctoral Clinical Nursing Research Fellowship for PhD-prepared RNs who remain employed at their home institutions. It was established in 2011 as a strategic nursing initiative.

Columbia Technology Ventures (CTV) is the technology transfer and commercialization office for Columbia University, including its medical center faculty and clinicians. CTV handles invention reporting, patent protection, licensing, startup formation assistance and industry collaboration agreements. It runs commercialization support programs and translational funding initiatives that help inventors bridge the gap between discovery and market. The office is based on Columbia's Manhattanville campus and works across engineering, basic science and clinical departments.

Virtually Integrated Care is CommonSpirit Health's system-wide virtual nursing program, in which remote nurses support bedside teams with admissions, discharges, documentation, education and second-nurse verification. The model was built internally and scaled across CommonSpirit's multi-state hospital footprint as a workforce and quality intervention rather than a purchased product. It sits alongside CommonSpirit's Care Base virtual hospital, robotic process automation for cancer-screening outreach, and an internally developed emergency department operations dashboard, which together form the system's operational innovation portfolio. VIC serves inpatient nurses and patients across CommonSpirit hospitals, and the system engages outside companies mainly through technology partnerships and its separate venture arm rather than through VIC directly. CommonSpirit's innovation work is led at the executive level by a Chief Strategic Innovation Officer.

CommonSpirit Ventures is the strategic investment arm of CommonSpirit Health, one of the largest nonprofit health systems in the United States, and describes itself as one of the longest continuously operating health system venture funds. It is currently deploying its fourth vehicle, a $250 million fund. Investment themes include extensions of the integrated delivery model, automation and operational efficiency through artificial intelligence, life sciences, and high-access convenient care. The fund co-invests alongside institutional venture firms including Andreessen Horowitz, NEA, Oak HC/FT and TPG. It is an investing vehicle rather than a studio, and it is managed alongside CommonSpirit's treasury and strategic investing function.

Connecticut Children's Center for Innovation supports pediatric innovation by building an ecosystem that links the health system's roughly 3,000 team members with entrepreneurs, investors and academic partners. It helps translate ideas into clinical solutions by providing resources, education and validation services aimed at improving child health outcomes. Innovators submit proposals through an online application that moves through a three-phase review evaluated by the Center for Innovation Advisory Committee. Its portfolio includes care delivery work such as the Care Coordination Collaborative Model and translational science such as regenerative medicine and tissue engineering for premature lung disease led by Christine Finck, MD, FACS. Outside parties engage as collaborators and investors, including partnerships with Trinity College, the University of Connecticut, the Accelerator for Biosciences in Connecticut and Biotechnology Business Consultants.

The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses. It evaluates submitted ideas for market potential and intellectual property protection, supports prototype development and funding acquisition, performs global market assessment, and connects innovations to industry partners. Inventors submit through an invention disclosure form, and the office offers both organization-led and inventor-led development pathways depending on who drives the project. Its revenue-sharing terms are published: a 50/50 split of net proceeds between Corewell Health and the inventors after cost recovery, with no revenue caps that would reduce inventor compensation. Outside companies engage the office as licensees and development or distribution partners for Corewell Health technologies. It is distinct from Corewell Health Ventures, the system's investment arm.

Corewell Health Ventures is the venture investment arm of Corewell Health, the integrated Michigan system created by the merger of Spectrum Health and Beaumont Health, which also owns the Priority Health plan. The fund invests in growth-stage companies with existing customers and at least $1 million of revenue, and it explicitly excludes pre-revenue startups, Class III medical devices, pharmaceuticals and biotech. Its thesis is anchored on Corewell's vision of personalized health that is simple, affordable and exceptional, and the payer-plus-provider structure lets it evaluate solutions on both sides of the risk equation. It makes direct investments and also commits capital to third-party venture funds, producing a large indirect portfolio. It invests rather than incubating companies.

The Center for Technology Licensing is the commercialization arm of Cornell University, with a dedicated office serving Weill Cornell Medicine in New York City. CTL manages patent filing, technology licensing and startup support for Cornell and Weill Cornell inventors. It negotiates license and option agreements with industry and works with faculty founders to spin out companies based on university technology. The office covers both the Ithaca campus and the biomedical research enterprise at Weill Cornell.

Dartmouth Health's Nursing Innovation Hackathon, described internally as a Shark Tank for nurses, is a two-day event that trains front-line nursing staff in design thinking and then has them pitch solutions to problems they face daily. The inaugural event ran January 26-27, 2023 at Dartmouth Hitchcock Medical Center and drew registered nurses, nurse practitioners, medical assistants, licensed practical nurses and licensed nursing assistants from across the system. Participants were split into teams, trained on design thinking and artificial intelligence, and judged on their pitches. The winning team was awarded a six-month mentorship with nursing innovation experts to develop its concept further. The event was organized by a Dartmouth Health nurse manager and backed by the system's chief nurse executive.

Texas Health Catalyst is Dell Medical School's health innovation accelerator, run out of the Office of Innovation and Entrepreneurship, which helps clinicians and researchers translate discoveries into commercial products. Selected teams receive milestone-based seed grants of up to $50,000 plus customized product development guidance from panels of industry and clinical experts. The program is sector-agnostic, supporting therapeutics, diagnostics, medical devices and digital health, and it deliberately couples money with structured mentoring hours rather than grants alone. Its annual Roundup & Rodeo event showcases funded UT health innovation teams to investors and industry partners, and the model has been published as a case study in NEJM Catalyst.

Duke's Office for Translation & Commercialization is the university-wide unit that identifies inventions from Duke faculty, graduate students and staff, protects them, and moves them to market through licensing to existing companies or the formation of new ventures. It was created in 2021 by a Duke Board of Trustees initiative that consolidated the former Office of Licensing and Ventures (established in 1986), Duke Capital Partners and the Gilhuly Accelerator Fund into a single 42-person organization. Services include patent and copyright strategy, market and competitive analysis, negotiation of licenses and industry contracts, and entrepreneurial mentoring for faculty founders. Its New Ventures Group provides business planning and investor introductions, Duke Capital Partners is an alumni-led investment network that supplies venture capital and guidance, and the Gilhuly Accelerator Fund pays for late-stage de-risking experiments on Duke technologies. OTC engages outside companies as licensees, sponsored-research and option partners, and through the annual Invented at Duke networking event.

The Duke Institute for Health Innovation (DIHI) is Duke Health's central innovation engine, created to catalyze transformative innovations in health and healthcare and to cultivate a community of innovation and entrepreneurship across Duke University and the health enterprise. It organizes its work around three pillars: innovation science and implementation, technology and innovation infrastructure, and workforce training and education. Its core operating model is an annual Innovation Request for Applications (RFA) that competitively funds emerging ideas from Duke faculty, staff, students, trainees and Duke University Health System personnel, with recent cycles prioritizing AI-driven solutions to clinical and operational problems. Funded teams are paired with DIHI's internal data science, design and implementation staff so that prototypes are validated inside live Duke clinical environments rather than in a lab. DIHI engages outside companies as technology and development partners on funded projects and through its work setting norms for clinical AI deployment.

The Health Innovation Lab is a 20,000-plus-square-foot facility at the Duke University School of Nursing, adjacent to Duke University Hospital, that advances nurse-led models of care and translates clinical ideas into practice. It functions as a pipeline for evaluating medical devices, digital health technologies and care delivery models, and has operated as a grant-funded internal accelerator in partnership with Duke Health and the Schools of Engineering and Medicine. In November 2024 Duke University Health System appointed a Chief Nurse Innovation Officer to drive a culture of innovation in nursing practice and act as liaison between Duke Health and the School of Nursing. The same leader directs the Health Innovation Lab. The lab organizes its portfolio around medical devices, digital health and care delivery models.

The Emory School of Medicine Innovation Center is a physical and programmatic hub that gives Emory clinicians and researchers the tools to move ideas from bedside observation to prototype and company. It houses 3D printing and bioprinting for anatomical models and device prototypes, micromachining and microfabrication for microfluidics and organ-on-chip systems, and the AppHatchery digital health incubator for app development, UX research and extended-reality projects. The center also runs an Innovation Certificate Program and bioentrepreneurship events that teach faculty and trainees the commercialization pathway. It sits alongside Emory's broader innovation infrastructure, including the Emory Biomedical Catalyst and the Lab2Launch coworking and wet-lab space for faculty startups on the Schinazi Family Innovation Floor.

Distinction in Medical Innovation is a formal designation track inside Emory's Internal Medicine residency for residents who want to build and implement medical innovations during training. Participants pursue structured coursework in medical innovation and entrepreneurship, mentor biodesign project teams, and volunteer with institutional or commercial innovation organizations, then graduate with the Distinction noted on their record. The track focuses on diagnostics, therapeutics, devices, mobile health and health IT, and holds quarterly meetings with invited speakers plus networking across Emory and Georgia Tech resources. It is explicitly aimed at producing independent physician entrepreneurs rather than only quality-improvement leaders.

The Emory Office of Technology Transfer manages the intellectual property generated by Emory University researchers and clinicians, bridging the gap between academia and industry. OTT handles invention disclosure, patent protection, licensing and startup support, and tracks statistics on disclosures, patents, licenses, revenue and startups by fiscal year. The office maintains a startup portfolio page and reports finance data publicly. It marked its 40th anniversary and reported stable invention disclosure and licensing activity in FY2025.

The Center for Data Science, founded in 2015, is a research center at Emory's Nell Hodgson Woodruff School of Nursing that advances nursing and healthcare data science and acts as a bridge between the school and healthcare institutions. Its flagship asset is Project NeLL, a proprietary suite of applications built by nurses for nurses that includes a repository of more than 2 billion de-identified electronic health records plus data visualization tools and a video library. The center runs the Project NeLL Scholars Program, a year-long data science immersion for Emory Healthcare nurses that pairs training with big-data research projects and peer-reviewed publication. It supports faculty, postdoctoral fellows, doctoral students and technical staff across computational science, nursing science and health informatics, and offers services including mentorship on genomic data, patent assistance and sensor development testing. Outside organizations engage as interdisciplinary collaborators and as healthcare partners applying the center's data-driven methods.

Endeavor Health Innovation is the system's front door for co-developing, piloting and scaling new health technologies inside a nine-hospital Chicago-area system. It gives outside innovators access to clinical experts, real operating care environments for real-world testing, and a structured pilot process, and it supports internally generated ideas through the Endeavor Health Catalyst fund. The team works with startups and established vendors on co-development agreements and maintains relationships with venture partners who bring companies into the system. It sits inside Endeavor's broader Research and Innovation division, alongside the system's clinical research enterprise.

Inception Health was launched in 2016 as a separately branded innovation and digital health company-building arm of Froedtert & the Medical College of Wisconsin, created in partnership with the AVIA Innovator Network. Its mandate was rapid testing and scaling of digital health solutions across the health network, with early project areas in patient experience, post-acute care and behavioral health. It operated as an internal studio that developed products and partnered with external digital health companies, and it co-invested with other health system venture arms. Froedtert ThedaCare has since decided to sunset Inception Health as an independent entity and fold its team into the parent health system by or before spring 2027. It should therefore be treated as an active but winding-down program.

Geisinger Ventures is the for-profit venture arm of Geisinger, the integrated health system and health plan serving 42 counties in central and northeastern Pennsylvania. Its stated purpose is to translate clinical and operational innovation into practical use and to reinvest returns back into the health system. The group has focused on commercializing discoveries in life sciences, genomics and proteomics with the goal of advancing personalized medicine, alongside operational and care-model innovations developed inside Geisinger. It was founded and led by a managing partner and staffed with principals recruited from the genomics industry. Note that public activity has been limited in recent years and current status could not be confirmed from a primary source.

The Steele Institute for Health Innovation is Geisinger's central innovation body, structured as a hub that coordinates nine internal development partner teams rather than as a single lab. Those partners are the Digital Transformation Office, Behavioral Insights Team, Clinical Redesign, Industry Partnerships, Health Innovations, Informatics Team, Intelligent Automation Hub, Payment Transformation and Artificial Intelligence. The institute's stated role is to support Geisinger's strategic pillars and translate the work of those teams into operational change across the system. It publishes a library of case studies covering machine learning, virtual reality, care gap closure and clinic utilization so that methods can be reused internally and externally. Outside organizations engage it through its Industry Partnerships team and a published contact inbox for collaboration or employment inquiries; it is distinct from Geisinger Ventures.

Bear's Den is Hackensack Meridian Health's innovation and investment program, launched in 2017, that convenes quarterly panels to evaluate healthcare ideas and inventions from entrepreneurs, venture capitalists, partners and the system's own 36,000 team members. Selected concepts receive strategic partnerships, funding and other support, and external companies can receive direct equity investment from the health network. Hackensack Meridian has used a dedicated fund to make these investments, including a $25 million vehicle reported in 2018. The internal track has produced clinical and operational improvements sourced from nurses, physicians and frontline staff across the network's hospitals. It functions as both an accelerator for outside companies and an internal idea-funding mechanism.

The Center for Discovery and Innovation (CDI) is Hackensack Meridian Health's translational research center, which the system describes as an academic accelerator embedded inside a health care system rather than a conventional university institute. It opened on May 30, 2019 in a 250,000-square-foot facility on the 116-acre On3 campus in Nutley and Clifton, New Jersey, the former Hoffmann-La Roche site known as the birthplace of interferon. CDI runs on what it calls an agile, incentive-driven model, bringing researchers, practicing clinicians and life sciences companies together to develop new diagnostics, treatments and preventive strategies in cancer, infectious disease, immunology and behavioral and neurocognitive health. It is funded through a mix of federal grants from the NIH and National Cancer Institute, individual and corporate philanthropy, venture philanthropy and venture capital. Outside life sciences companies engage CDI as research collaborators and co-development partners, and the center also serves as the research hub for the adjacent Hackensack Meridian School of Medicine.

Hartford HealthCare runs a system-level innovation function that partners with venture investors to source, pilot and back early-stage digital health and healthcare technology companies in Connecticut. In December 2022 it announced a partnership with Connecticut Innovations, the state's quasi-public venture capital arm, to accelerate digital health solutions developed in Connecticut and to support a cohort of 20 Hartford-based startups. The arrangement gives startups structured access to Hartford HealthCare clinicians to test concepts and products in a live clinical environment, while advancing state economic development and job creation goals. Hartford HealthCare has also partnered with the Upward Labs AgeTech Fund on aging-focused technology. It combines an innovation center model with venture partnership rather than running a large captive fund.

The HealthTech Fellowship, launched by Harvard Medical School in 2020 and facilitated through its Center for Primary Care, is a 10-month immersion that applies the biodesign framework to healthcare problems. Fellows work in multidisciplinary teams that begin with field observation alongside clinical partners to identify unmet medical needs, then move into concept development and business development. Fellows work directly with physicians and receive mentorship from faculty, entrepreneurs, inventors and venture capitalists. The program runs annually from August through May and draws resources from Harvard Medical School and its affiliated hospitals, the Harvard John A. Paulson School of Engineering and Applied Sciences, and Harvard Business School. Outside companies and investors engage as mentors and as the downstream commercialization path for fellow projects.

Care Transformation and Innovation is HCA Healthcare's internal department for redesigning care delivery and moving technology into clinical workflows across the company's hospitals. Its leader describes it as "the funnel for innovation all over the organization," and it sits within HCA's Clinical Services Group with a mixed staff of clinicians, data scientists, engineers, operations, change management and finance people. CT&I builds and deploys products such as a machine-learning staff scheduling platform and ambient clinical documentation, and pilots them at designated Innovation Hub hospitals before scaling. It engages outside companies primarily through large technology partnerships, including a collaboration with Google Cloud on a data analytics platform and clinician mobile tools, rather than through an open startup accelerator. The related Digital Transformation and Innovation organization recruits engineers, product leaders and data scientists who work directly alongside hospital care teams.

Sarah Cannon Research Institute is the oncology research and drug-development organization founded within HCA Healthcare that runs community-based cancer clinical trials. It operates a large network of affiliated physicians and research sites that gives community oncology patients access to early-phase and pivotal trials close to home. SCRI runs first-in-human and early-phase studies for pharmaceutical and biotechnology sponsors, functioning as the bridge between industry drug developers and community cancer programs. Since 2022 it has operated as part of a joint venture that combined SCRI with McKesson's US Oncology Research, with McKesson holding majority ownership and operating control. It engages outside companies as a contract and collaborative research partner for sponsors seeking trial sites, data and investigator expertise.

The Davidson Fellowship is a nine-month professional development program at Henry Ford Health that equips clinicians and administrative leaders with innovation and entrepreneurship skills. Running September through June with monthly meetings and roughly eight hours of monthly outside work, it combines a lecture-based curriculum with team projects tackling real Henry Ford Health challenges. Content covers financial modeling, intellectual property, regulatory navigation and pitch and presentation skills. The program deliberately mixes departments so that fellows build cross-functional networks, and solutions developed by fellow teams can be routed toward commercialization through Henry Ford Innovations.

Henry Ford Innovations advances inventions developed by Henry Ford Health clinicians and researchers while also sourcing external technologies for the system. It operates an Innovation Hub combining clinical expertise, startup engagement and venture investment. The program pilots early-stage company technologies in Henry Ford clinical settings and evaluates them for system-wide adoption. It also runs an internal 3D printing program supporting clinical care and surgical planning.

Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation. The fund invests at pre-seed through Series A in precision medicine, digital health, artificial intelligence, medical devices and remote monitoring, drawing on discoveries from both institutions. It sits alongside Henry Ford Innovations, the system's long-running commercialization office, which secures intellectual property on employee inventions, structures industry partnerships and runs clinical 3D printing services. Together the two functions cover invention through capital. The fund announced its first two investments in 2026.

Highmark Ventures is the corporate venture capital arm of Highmark Health, the Pittsburgh-based integrated delivery and financing organization that owns Allegheny Health Network and the Highmark health plans. Operating since 2010, it invests in companies that advance the enterprise strategy of transforming both care delivery and care financing, which gives it a payer-and-provider dual lens. Its declared investment themes are value-based experience and care models, data and analytics, personalized patient and member experience, pharmacy, behavioral health, and social determinants of health. The team is structured with a managing partner, managing director and director. It invests for long-term strategic value creation rather than operating a studio.

The HSS Innovation Institute develops and commercializes musculoskeletal healthcare technologies originating from Hospital for Special Surgery clinicians and researchers. Its work spans three domains: care delivery, covering digital health and data technologies; medical devices and instrumentation; and life sciences, covering drugs, biologics and research innovations. The institute pursues technology development, licensing, product co-development, strategic collaborations, joint ventures and spin-off companies. Its expertise areas include bone health and implant integration, inflammation and arthritis, joint preservation and regeneration, musculoskeletal pain, sports performance and rehabilitation, and data science and analytics. Outside companies engage through co-development agreements, licensing and joint ventures, with a meeting request pathway on the institute's innovation portal.

The Houston Methodist Center for Innovation leads organizational transformation through technological enablement across the health system. Its projects include smart hospital rooms, AI-driven predictive care, ambient intelligence and call center automation. The center pursues a portfolio of near-term deployments alongside longer-horizon 'Future Bets' and publishes case studies of prior work. Its stated aim is to combine innovative technology and design to improve patient safety, quality and efficiency.

The Indiana University Innovation and Commercialization Office collaborates with faculty, industry and entrepreneurs to commercialize innovations arising from IU research, including the IU School of Medicine. ICO manages invention disclosures, patent applications, licensing agreements and startup formation across IU's Bloomington and Indianapolis campuses. It provides startup resources and connects inventors with industry partners and investors. The office publishes annual and multi-year metrics on its commercialization pipeline.

The IU Health Incubator at IU LAB is Indiana University Health's sponsored startup incubator inside the Indiana University LifeSciences Accelerator and Biofoundry, created to translate research into companies and grow the state's life sciences economy. It runs two programs: a seven-week pre-accelerator using gener8tor's gBETA curriculum for up to 10 early-stage human health companies a year, and a LifeTech Accelerator operated jointly with Plug and Play and the Central Indiana Corporate Partnership that takes 20 to 30 companies a year across two cohorts. Startups get mentorship, curriculum, introductions to IU Health clinicians and access to IU LAB facilities. The incubator is open to companies from Indiana and outside the state that want a clinical partner and a landing point in Indianapolis.

Inflect Capital is the venture-investment offering of Inflect, a healthcare innovation platform backed by the physician-owned and physician-led partnership Vituity. Inflect describes Capital alongside Studio and Network offerings, creating a provider-backed model that combines early-stage investment with company building and access to healthcare expertise. The Capital program invests from pre-seed through Series A in companies addressing healthcare delivery and operating challenges. This profile treats Inflect as a provider-backed platform rather than a hospital-owned corporate venture arm because the official site establishes Vituity's backing but does not describe ownership by a hospital or health system.

Inova launched Inova Strategic Investments and the Inova Personalized Health Accelerator together in 2016 as paired vehicles for external innovation. Inova Strategic Investments commits capital both to healthcare venture funds and directly to companies aligned with the system's priorities in advanced analytics, clinical innovation and information technology. The accelerator, which formally opened in November 2017 at the Inova Center for Personalized Health in Northern Virginia, hosts entrepreneurial companies developing personalized health and genomics-driven solutions and gives them physical space and clinical access. Both were stood up under experienced venture managing directors recruited from the Washington-area technology investment community. Inova has also been a limited partner in multi-system funds such as Ascension Ventures.

The Intermountain Foundry is Intermountain Health's internal accelerator for employee-generated innovation, turning promising caregiver ideas and near-market concepts into commercial ventures. Participants go through a structured eight-week program in which they refine the business concept, assess commercial viability, identify remaining development needs and build a plan to scale the idea inside Intermountain or across the broader healthcare industry. It was created as one of three pillars of the Innovation at Intermountain initiative, alongside strategic investments in outside healthcare companies and an accelerator run with Healthbox in Salt Lake City. Outside companies and investors engage through the Healthbox partnership and through the shark-tank style review panels that evaluate Foundry projects. The program is open to Intermountain employees across the system's hospitals and clinics.

Intermountain Ventures is the official venture capital and innovation arm of Intermountain Health. The health system's ventures page states that the team invests in and partners with companies to improve healthcare delivery, operations, patient experience, and outcomes. Official copy lists six investment areas: enterprise enablement, care site optimization, workforce transformation, consumer experience, clinical advancement, and proactive care. The page states that Intermountain Ventures funds early- and growth-stage companies and provides access to Intermountain's integrated system for proofs of concept, clinical trials, and pilot programs. It also publishes a current list of portfolio companies, including Artisight, Axuall, Freenome, Maven, Omada, and others. A June 2025 Layer Health announcement, quoting Nickolas Mark as Managing Partner of Intermountain Ventures, described a strategic investment and a multi-year AI deployment with Intermountain Health. This profile uses the official ventures page as the primary source and treats the 2025 announcement as secondary confirmation of current leadership. It does not evaluate portfolio performance.

Jefferson Innovation is the entrepreneurial and commercialization organization spanning Jefferson Health and Thomas Jefferson University. It manages invention disclosures, patent protection, licensing and startup formation for the Jefferson community, and provides mentorship and education to clinician and faculty inventors. Its programs include the Jefferson Accelerator Zone for startup development, the Health Design Lab, the JeffSolves product-development competitions, and Jefferson Health Hack. Leadership includes a chief innovation officer at the executive vice president level and a dedicated vice president for licensing and startups. It is a builder and licensor of internal innovation rather than an external venture fund.

Jefferson Ventures is the commercialization hub for Thomas Jefferson University and Jefferson Health, connecting clinicians, scientists and students with industry and strategic collaborators. It manages the university's patent portfolio, out-licenses inventions and supports the launch of startup companies based on Jefferson discoveries. The office also structures partnerships with corporate collaborators seeking access to Jefferson technology and clinical expertise. It is headquartered at 1101 Market Street in Center City Philadelphia.

JeffSolves MedTech is a transdisciplinary medical device innovation program run through Jefferson's Health Design Lab that pairs medical students and clinicians with industrial design and textile design students. Teams begin with user research alongside Jefferson clinicians and patients to surface real clinical pain points, then move through intensive product development training led by experts from Thomas Jefferson University, Jefferson Health and the design firm Delve. Projects are prototyped, refined and pitched publicly, including at Design Philly Festival events. The program has produced both patent-pending devices and commercially launched products, and it is co-directed by a mixed clinical and design faculty team.

Johns Hopkins Technology Ventures (JHTV) publishes a technology-transfer and entrepreneurship platform for moving discoveries from the university and its research community toward products and services. Its official Technology Transfer page says the group partners with inventors, helps identify companies or investors interested in a technology, negotiates license agreements, maintains relationships with companies developing licensed technology, and advises faculty on commercialization paths. JHTV's Programs and Services page names FastForward as a coordinated set of resources for startups moving from startup to marketplace, along with cohort-based programs, mentorship, and a Commercialization Academy. This profile uses Johns Hopkins Medicine as the health-system context while preserving the official JHTV description of its broader academic research remit. It does not infer that every supported startup is a Johns Hopkins Medicine spinout.

Johns Hopkins CBID sits at the intersection of the Whiting School of Engineering and the Johns Hopkins School of Medicine and trains teams to invent, prototype and commercialize medical devices. Its intensive one-year Master of Science in Engineering program compresses two to three years of design education into a single year, with students completing clinical rotations inside Johns Hopkins Medicine and at international sites before building devices against observed needs. Clinical faculty and Hopkins physicians serve as project sponsors and mentors, so device concepts originate from real bedside problems. CBID's stated dual mission is education plus innovation, both in the service of human health, and student teams routinely spin their projects into funded startups.

The Sibley Innovation Hub is the in-house innovation team at Sibley Memorial Hospital, a Johns Hopkins Medicine community hospital in Washington, DC. It works through what it calls the Sibley Innovation Method, which combines human-centered design, digital services and lean process improvement to advance patient-centered care. The team's stated approach is to listen to the needs of people, build creative solutions and then scale them rapidly across the hospital. It engages a broad set of participants including patients and families, clinical staff, physicians and external partners in developing and implementing innovations. Its work sits inside Johns Hopkins Medicine but is run locally at the community hospital rather than through the university's central commercialization arm.

The Care Management Institute is Kaiser Permanente's clinical knowledge and care-redesign body, established in 1997 and co-sponsored by the Permanente Medical Groups and Kaiser Foundation Health Plan. CMI develops evidence-based clinical practice guidelines and clinician guides through systematic evidence reviews and rapid reviews on high-priority clinical topics. It then works with regional care delivery teams to spread those practices, applying improvement science so that, in its own formulation, the right thing is the easy thing to do. It runs care-redesign and chronic disease and prevention programs, and it explicitly incorporates patients and families onto innovation teams that design care pathways. It serves Kaiser Permanente physicians and regional operations rather than external customers, and is distinct from Kaiser Permanente Ventures.

The Garfield Innovation Center is Kaiser Permanente's simulated care delivery environment, where clinicians, designers and technologists prototype, test and refine both high-tech and low-tech care improvements before they are deployed across the system. It replicates hospital and clinic settings so that new workflows, equipment, facility designs and technologies can be trialed with front-line staff rather than in live patient care. Kaiser Permanente uses it to test ideas that then scale system-wide, such as the KP MedRite medication administration protocol, interactive patient care technology, smart hospital beds with fall detection, and telemedicine models under its Imagining Care Anywhere initiative. Outside vendors and technology companies engage by bringing products into the center for simulation and evaluation against Kaiser Permanente care models. The center serves Kaiser Permanente's clinical and operational teams nationally.

Kaiser Permanente Ventures is the corporate venture capital arm of Kaiser Permanente. The official About page states that the program was founded more than 25 years ago and that, in partnership with Kaiser Permanente and limited partners, the team has invested in and helped support more than 67 companies. Fund targets listed by the firm are health information technology, digital health, healthcare services, medical devices, and diagnostics and precision medicine. A 2018 Permanente Medicine announcement stated that Kaiser Permanente Ventures closed Fund V at $141 million, bringing assets under management to more than $500 million at that time, and that the firm had invested in more than 70 companies since 1998. That announcement also named Tufts Health Plan, Henry Ford Health System, and Highmark Ventures among Fund V limited partners. Official team materials identify Chris Grant as a co-founder of the 1998 investment program who continues to oversee ventures. This profile describes the publicly documented venture model only. It does not imply that Kaiser Permanente lacks other innovation functions, and it does not evaluate fund performance.

The USC Stevens Center for Innovation is the University of Southern California's technology licensing office, serving inventors across the university including the Keck School of Medicine and Keck Medicine of USC clinical enterprise. It helps researchers move discoveries from the lab to the marketplace through three core functions: protecting intellectual property with patent and copyright guidance, partnering researchers with industry collaborators, and commercializing innovations through licensing agreements and startup formation. The office also administers proof-of-concept funding and startup support resources for faculty and clinician founders. Outside companies engage by licensing USC technologies, sponsoring research and partnering with USC startups. The center was founded in 1971 as the Office of Technology Licensing and renamed in 2007 following a $22 million endowment from Mark Stevens in 2004.

The Lankenau Institute for Medical Research (LIMR) is Main Line Health's biomedical research institute, founded in 1927 and based at Lankenau Medical Center in Wynnewood, Pennsylvania. Unlike a conventional academic institute, LIMR operates on what it calls an ACAPRENEURIAL model, in which invention, intellectual property and new company development are the primary goal and new academic knowledge is the secondary one. To execute that model it runs an intellectual property licensing division, a biotech incubator and Lankenau Ventures, its vehicle for forming and supporting companies around LIMR discoveries. Research programs span cancer and immunotherapy, cardiovascular disease drug and device development, autoimmune and gastrointestinal disease, and it operates its own clinical research center so discoveries can be tested in Main Line Health patients. Outside companies engage LIMR as licensees, incubator tenants and clinical trial sponsors.

The MaineHealth Innovation Center, founded in 2020 and based at Maine Medical Center in Portland, describes itself as the connective tissue between research, education and care for a system of roughly 23,000 employees serving about 1.1 million patients in Maine and New Hampshire. It defines innovation as a novel idea that solves an unmet care need through new care team models, products or services, and supports care team members from idea through commercialization. Its programs include the Innovation Cohort, a free ten-week structured program; the Innovation Blender; an Innovation Funding Program with the Ignite Fund providing up to $20,000 in seed capital and Bonfire Funding providing up to $100,000 for care team member startups; innovation workshops and innovation in education. A dedicated intellectual property and technology transfer function handles patenting and licensing of employee inventions. Outside entrepreneurs and companies engage as mentors, co-development partners and follow-on investors in Bonfire startups.

Mass General Brigham Innovation is the business development arm of the health system. Official pages state that the group is responsible for the worldwide commercial application of discoveries made by Mass General Brigham employees and that it coordinates industrial relationships and intellectual property management across Brigham and Women's Hospital, Massachusetts General Hospital, Mass Eye and Ear, McLean Hospital, and Spaulding Rehabilitation. The office reports responsibility for industry collaborations, venture investing, licensing, company creation, technology marketing, open innovation alliances, and workforce development. Official leadership materials identify Chris Coburn as Chief Innovation Officer and state that his team annually stewards $150 million of revenue, about 30 spin-offs, and nearly 300 licensing transactions, with a venture investment arm of nearly $500 million under management. Mass General Brigham Ventures is described as an early-stage venture firm founded in 2008. A separate Artificial Intelligence and Digital Innovation Fund, founded in 2020 with a $30 million commitment, invests in venture-stage companies aligned with system strategy.

The Brigham Digital Innovation Hub, founded in 2013 at Brigham and Women's Hospital as the iHub, drives digital health innovation across Mass General Brigham and now operates as part of Mass General Brigham Emerging Technologies and Solutions. It performs three core functions: matching market solutions to organizational challenges, accelerating development and commercialization of solutions created internally by clinicians and employees, and building a collaborative digital health community. It serves clinicians, employees and patients across the system by advancing clinical and operational digital solutions and accelerating digital research activity. Outside companies engage explicitly through solution matchmaking, in which the hub connects market-based technologies to internal institutional needs. Inquiries are handled through a contact form on the hub's site.

The Center for Innovations in Care Delivery is Massachusetts General Hospital's formal structure for surfacing and developing ideas that originate with front-line nurses and other direct-care staff. Nurses submit clinical problems they encounter at the bedside, and the center pairs them with engineers, researchers, designers, operational leaders, manufacturers and patients to prototype, test, measure and scale solutions. Its signature vehicle is the IDEA (Innovation, Design, Excellence, Awards) program, which awards seed grants and provides months of one-on-one mentoring in human-centered design methodology. The center also anchors MGH's investment in nursing innovation infrastructure through an endowed chair dedicated specifically to nursing innovation. Work developed through the center has moved as far as patenting and clinical trials.

Mayo Clinic's Department of Business Development, which includes Mayo Clinic Ventures, is described as Mayo Clinic's front door to business and is the route by which Mayo physicians and scientists commercialize their inventions. It operates across three functions: protect and develop, covering intellectual property management, technology funding and product development; launch and grow, covering licensing agreements, startup formation and equity investments; and partner and scale, covering strategic collaborations, mergers and acquisitions. Physician inventors bring disclosures into this pipeline and can end up as founders of Mayo-affiliated startups or as licensors to established medtech and pharma companies. Returns from these activities are cycled back into Mayo's clinical practice, education and research missions.

Mayo Clinic's Department of Business Development is the official front door for technology commercialization, startup formation, equity investment, and strategic partnerships. The department's public site describes two divisions, Mayo Clinic Ventures and Corporate Development, working as one team. Official pages state that more than 440 startups use Mayo Clinic technology, that more than $400 million in investment capital has been deployed for strategic collaborations and equity investments, and that more than $1.3 billion has been returned to Mayo Clinic to support practice, education, and research from inception through 2025. The department reports that it licenses intellectual property, forms companies, runs a business accelerator, and participates in a multimillion-dollar venture and growth fund. Andrew J. Danielsen is publicly identified as Chief Business Development Officer, and Peter A. Noseworthy, M.D., is identified as Medical Director. This profile summarizes official Business Development pages only and does not interpret the reported figures as a ranking or performance judgment.

The Medical College of Wisconsin Office of Technology Development is the technology transfer office for MCW, the academic partner of Froedtert ThedaCare Health, operating under the tagline From Patents to Patients. It manages MCW discoveries, inventions and other intellectual property assets, guiding faculty inventors through disclosure, patent protection and licensing. The office supports inventors, entrepreneurs and industry partners who want to license MCW technology or build startups around it. Its staff includes dedicated licensing and intellectual property managers who handle agreements with companies across therapeutics, diagnostics and devices.

The Zucker Institute for Innovation Commercialization is an independent entity powered by MUSC that evaluates and manages the intellectual assets generated by MUSC faculty, physicians and staff. It works alongside the MUSC Office of Innovation to take clinician inventions through disclosure, patenting, prototyping, market assessment, licensing and startup formation. The institute maintains specialized leadership across medical technology, digital health and creative works, and intellectual property administration, so device, software and content inventions each get matched expertise. Its board draws from MUSC leadership including the health system's Chief Administrative Officer, Chief Innovation Officer and Vice President for Research, keeping the commercialization pipeline tied to institutional strategy.

The MedStar Institute for Innovation, known as MI2, was founded in 2009 as MedStar Health's system-wide innovation organization spanning Maryland and Washington, DC. It develops and deploys technical capabilities including telehealth, simulation, data science and emerging technologies to enable new care delivery models. MI2 is organized into labs: the Business Innovation Lab, the Care Innovation Lab and Telehealth, the Information Innovation Lab, the MedStar Health Simulation Training and Education Lab, and the Center for Wellbeing. The Business Innovation Lab runs venture and inventor services and an innovation incubator that supports startup clinical and operational programs. It builds and commercializes internal innovation rather than operating as an external venture fund.

This one-year physician fellowship is a joint effort of MedStar Georgetown University Hospital, MedStar Washington Hospital Center and the MedStar Institute for Innovation (MI2), designed to prepare emergency physicians for clinical and operational leadership of health-system digital health programs. Fellows spend roughly 60 percent of their time as attending physicians, including at a Level 1 trauma center, while completing immersive innovation training. The curriculum covers telehealth technology, artificial intelligence, workflow design, healthcare economics and regulatory compliance, and fellows also complete the MedStar Emergency Physicians LEAD program plus a scholarly or research project. Alumni report the fellowship broadened their impact and opened entrepreneurship opportunities alongside health-system leadership roles.

The Institute for Nursing Excellence is Memorial Hermann's system-level nursing institute, described as built by nurses for nurses, with fostering innovation and accelerating adoption of best practices as one of its five stated goals alongside workforce, evidence-based practice, interdisciplinary role and outcomes goals. It runs nurse manager idea labs that surface recruitment and retention solutions, pilots telenursing to reduce workload, and tests new retention-focused care models aimed at burnout. The Institute created a Professional Governance Congress to amplify nurse voice and built dedicated training facilities at the Texas Medical Center and in west Houston with classrooms, simulation labs and workflow optimization space. It engages outside organizations through The Health Management Academy's Workforce Innovation Collaborative Nursing Catalyst and through partnerships with Houston-area educational institutions. It also convenes an external-facing Nursing and Clinical Innovation Summit that solicits abstracts.

Memorial Hermann runs a strategic investments, partnerships and innovation function that takes equity positions in healthcare companies whose products the system can deploy. The program organizes around two objectives: strengthening core inpatient and outpatient care delivery, and augmenting illness prevention through early access, holistic health and wellness interventions. Priority themes include patient experience, health equity, access, high-reliability care delivery, digital and analytics innovation, and the transition to value-based care. The system has disclosed a portfolio of more than 40 companies, one of the largest published provider portfolios in the country. Investments are typically paired with commercial deployment inside Memorial Hermann.

The Office of Entrepreneurship and Commercialization is Memorial Sloan Kettering's technology commercialization arm, renamed from the Office of Technology Development in October 2024. It manages MSK's portfolio of intellectual property and entrepreneurship opportunities across life sciences, digital health and broader healthcare. The office supports the full arc of translation, from evaluating laboratory discoveries and filing patents through startup formation and licensing deals with pharmaceutical and device companies. It also structures industry partnerships and sponsored collaborations for MSK investigators and clinicians. Outside companies engage through licensing of MSK inventions, co-development agreements and equity partnerships in MSK-founded startups.

The MemorialCare Innovation Fund is the strategic venture capital arm of MemorialCare Health System, a roughly $2 billion revenue Southern California nonprofit system. It provides growth capital to early- and mid-stage companies in healthcare information technology, healthcare services and medical devices. The fund is run by dedicated managing directors and is governed by a board chaired by MemorialCare's chief executive, with the system's chief medical officer and chief strategy officer also involved. Its differentiator is access to MemorialCare's hospitals, medical groups and outpatient network for validation and commercial reference. It is one of the longer-running provider venture funds on the West Coast and has produced multiple strategic exits.

Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan. Its public materials say FFMI provides resources, support, mentorship, funding education, and commercialization guidance to biomedical researchers, students, collaborators, and industry partners. The program page names commercialization education, mentorship and funding, corporate-partner support, the Michigan Biomedical Venture Fund, and FFMI fastPACE among its offerings. The FFMI innovation-portfolio page also lists programs including the Frankel Cardiovascular Center Innovation Program, Rogel Cancer Center Innovation Program, Innovation Studio, and intellectual-property education. This profile records the published program structure and types of support without claiming that a funded project, portfolio company, or institutional partnership achieved a particular result.

The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs. Project teams receive translational funding plus commercialization coaching and milestone oversight from the program director and an oversight committee. Success is measured by whether a funded concept advances far enough to attract an industry licensee or to launch a startup that raises investor capital. The program is housed in the Department of Biomedical Engineering at Michigan Engineering and works alongside the university's technology transfer and venture teams.

Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research. It is organized into three teams: Alliances for industry research relationships, Licensing for intellectual property commercialization, and Ventures for startup formation. The office provides intellectual property strategy, licensing, startup formation and industry engagement support to faculty, staff and student inventors. It also invests directly in university spinouts through the Accelerate Blue Fund, an early-stage venture fund, and publishes annual impact reports going back to 2001.

The Michigan Biomedical Venture Fund is an early-stage investment program within Fast Forward Medical Innovation at the University of Michigan Medical School. It supports biomedical companies based on University of Michigan intellectual property and is positioned inside the medical school's commercialization pathway rather than as a general-purpose health-system corporate venture fund. The program evaluates opportunities arising from university research and supplies capital and commercialization support intended to move promising biomedical technologies toward company formation, external financing, and patient impact. Its official placement within Fast Forward Medical Innovation connects investment decisions with broader education, product-development, industry-partnership, and technology-transfer resources.

The Montefiore Einstein Innovation Biodesign Training Program is a one-year fellowship-style experience designed to train clinician innovators inside the health system. Participants take health-technology coursework covering digital health, market assessment, intellectual property, regulatory strategy, product validation, funding models and financial operations. The curriculum pairs didactics with clinical immersion, in which trainees observe care to identify unmet needs, and with an innovation project that culminates in a pitch to institutional leadership. It serves Montefiore Einstein faculty and fellows, with an explicit focus on chronic disease burdens affecting Bronx patients and providers. Trainees are mentored by Montefiore Einstein faculty alongside external industry and entrepreneurship experts.

The Office of Biotechnology and Business Development is the technology transfer and industry-partnering office for Albert Einstein College of Medicine within the Montefiore Einstein system. It handles the full commercialization workflow, from intellectual property disclosures and patent management through contract execution, licensing and material transfer agreements. The office markets a licensing portfolio of Einstein technologies spanning therapeutics, diagnostics, research tools and vaccine platforms, and manages relationships with pharmaceutical companies and venture capital firms. It also runs a Technology Transfer Intern Program that trains graduate students and postdocs in commercialization, along with seminars and events for faculty inventors. Outside companies engage through licensing, sponsored research and collaboration agreements negotiated by the office's licensing and contracts staff.

The Center for Nursing Research and Innovation supports federally funded research led by Mount Sinai nurse scientists and facilitates multidisciplinary translational research intended to improve patient care and strengthen nursing practice through innovation and collaboration. It serves clinical nurses across the Mount Sinai Health System who are running research and quality improvement projects, as well as nursing students, and staffs the work with a director, associate director and five additional nurse scientists. The center administers four structured training programs: the NIH-sponsored 12-week Translational Research and Implementation Science for Nurses (TRAIN) program for DNP students from disadvantaged backgrounds, the ten-week paid Learning in Virtual Environments (LIVE) summer program, the nine-week Interdisciplinary Collaborative Research (iCORE) training program, and an Evidence-Based Practice Fellowship. Outside organizations engage primarily as funders and sponsors, including the NIH, the American Heart Association and the Rudin Foundation. The center also publishes an open-access peer-reviewed journal, Practical Implementation of Nursing Science (PINS).

Mount Sinai BioDesign is a medical device innovation incubator embedded in the Mount Sinai Health System that turns clinical insights from its physicians and surgeons into commercially viable medical technologies. It runs an end-to-end process spanning needs identification with clinicians, rapid prototyping and digital manufacturing, device design and validation, and intellectual property protection. Completed technologies are licensed to industry partners or spun out into new companies. It partners with Mount Sinai clinicians across neurosurgery, cardiology, otolaryngology and orthopedic surgery, and works with external industry partners that want to accelerate device development. It is directed by the health system's chair of neurosurgery with a neurosurgeon-entrepreneur as scientific director.

The i3 Asset Accelerator is Mount Sinai Innovation Partners' milestone-driven investment program for advancing discoveries by Mount Sinai faculty, physicians and researchers toward commercial viability. Technologies are nominated by MSIP business development staff and then reviewed by an Investment Advisory Committee of venture capitalists, entrepreneurs and industry professionals from pharma, biotech and medical devices. Selected projects receive staged funding tied to defined commercial inflection points, with the explicit goals of generating stronger intellectual property, licensing assets to corporations or new startups, and attracting outside investment. Projects are judged on commercial inflection point, market potential, technological novelty and clinical relevance.

Mount Sinai Innovation Partners (MSIP) is the commercialization organization for the Mount Sinai Health System and the Icahn School of Medicine, handling patenting, licensing, research partnerships and entrepreneurship. In 2018 the Icahn School of Medicine capitalized the i3 Asset Accelerator with an initial $10 million to fast-track commercially relevant discoveries toward patients using a milestone-based development strategy. The accelerator is guided by an advisory team of more than 40 scientists, business professionals and commercialization experts who both allocate funding and steer development. Early funded assets included a novel drug-development platform for cancer and therapies for influenza B. The combination gives Mount Sinai an internal capital vehicle for its own science rather than an external venture fund.

MultiCare Capital Partners is the innovation and strategic investment arm of MultiCare Health System, the largest community-based, locally governed health system in Washington State. It describes its role as a bridge between MultiCare and the broader entrepreneurial ecosystem while advancing the system's healing mission. The group makes venture investments in healthcare startups and health technology companies, and it raised a dedicated first fund vehicle. Investment activity is paired with the ability to pilot inside MultiCare's hospitals, clinics and ambulatory network in the Puget Sound region. It invests rather than building companies in-house.

Nationwide Children's Hospital publishes an Office of Technology Commercialization and an Innovation Center within its pediatric research environment. The official technology-commercialization page says the office offers technology-transfer expertise and facilitates partnerships between inventors and industry to bring discoveries to patients, clinicians, and scientists. The Innovation Center page describes a team of clinicians, researchers, and engineers advancing patient care through medical-device innovation, design, and commercialization. It states that the center was founded in 2022 to discover, develop, and deliver pediatric innovations, support commercialization of hospital-born inventions, and educate future innovators. The official team page identifies Neil Veloso as Vice President for Innovation and Technology Commercialization, overseeing both functions. This profile records those stated roles without inferring licensing results, company ownership, revenue, or commercial performance.

The Innovation Design Unit is a 17-bed inpatient unit at Nebraska Medical Center that operates as a living laboratory where nurses, technologists, designers and patients co-develop and test new care delivery approaches before they are spread system-wide. Virtual nursing is a central feature, with remote nurses supporting bedside teams on admissions, discharges and patient education. The unit tests patient-controlled room environments via iPad, digital care plan visibility, medication tracking, virtual family visitation, ceiling lift technology for safe patient mobility, and AI for fall-risk detection. It is led jointly by a scientific director and a nurse executive who serves as Executive Director of System Care Delivery and Innovation. The unit opened in January 2025 after multi-year planning with CannonDesign and RDG Planning & Design.

The Nemours Office of Technology Transfer (OTT) manages and protects intellectual property generated across Nemours Children's Health and converts pediatric research discoveries into commercial products through strategic industry partnerships. It runs the invention disclosure process, evaluates patentability, prepares and prosecutes patent applications with the USPTO, and negotiates licensing agreements. OTT also handles the contracts that surround research collaboration, including material transfer agreements, data use agreements and confidentiality agreements. It markets Nemours innovations to pharmaceutical, biotechnology and medical device firms, and supports Nemours inventors who want to form startups by guiding company formation and connecting them to venture funding. The office additionally provides commercialization education, helps identify research funding sources and administers IP revenue sharing for inventors.

NYP Ventures is the strategic investment fund of NewYork-Presbyterian, launched in November 2016 to back digital health companies whose products can be tested and scaled inside the academic medical center. The fund emphasizes telehealth, virtual care and digital patient experience, reflecting NewYork-Presbyterian's early investment in its NYP OnDemand telehealth platform. Its debut investment was in Avizia, a telehealth hardware and software company. NYP Ventures invests alongside institutional venture firms and provides portfolio companies with clinical validation across NewYork-Presbyterian's campuses and its Columbia and Weill Cornell affiliations. It is an investing vehicle rather than a company-building studio.

Northwell Health's Institute for Nursing is the system's structure for nursing research, evidence-based practice and nurse-led innovation across its hospitals. Northwell runs a bi-annual Innovation Challenge open to all team members, including nurses, in two categories: innovation in science (therapeutics, diagnostics, medical devices) and innovation in care delivery. Six finalist teams pitch to a judging panel each year and winning teams receive research and development funding. Separately, Northwell hosted a two-day NurseHack4Health innovation sprint with Johnson & Johnson and SONSIEL, embedded into its annual nursing leadership retreat, to push design-thinking methods into nursing culture at scale. The system's chief nurse executive championed the hackathon and the resulting ideas now feed Northwell's nursing strategic plan.

Northwell Holdings is the official for-profit investment and commercialization arm of Northwell Health. The health system's Holdings pages state that the unit invests in early-stage and growth opportunities, forms strategic partnerships, and cultivates internal innovations that can create diversified revenue streams. Official copy says Holdings develops and commercializes internal innovations invented by Northwell team members, brings products and medical devices to market, advances data assets, and forms joint ventures. An overview page states that Northwell Holdings was established in 2013 and that its strategy seeks private-equity and venture-class returns from companies that can diversify revenue and add contribution margin. Richard Mulry is publicly identified as President and CEO of Northwell Holdings. Separate official materials describe the Center for Learning and Innovation as Northwell's corporate university and the home of a 3D design and innovation lab, and they describe a system Innovation Challenge. This profile treats Holdings as the primary commercialization vehicle and notes the learning-and-innovation functions as related program elements. It does not evaluate financial returns.

Innovation and New Ventures Office (INVO) supports the transition of Northwestern University research into practical applications, including work from the Feinberg School of Medicine and Northwestern Medicine clinicians. INVO provides guidance on invention disclosure, patenting, licensing and startup development. The office operates through three hubs: Innovation Commercialization, the Querrey InQbation Lab, and The Garage student venture space. It publishes an annual Inventive Activity Report documenting disclosure, patenting and licensing volumes.

Novant Health Enterprises is an independent business division launched by Novant Health in March 2022 to incubate, acquire and commercialize healthcare businesses rather than to make passive minority investments. It concentrates on three areas: developing transformational clinical capabilities, expanding into non-acute care settings, and commercializing differentiating digital solutions. The division is structured to partner with other healthcare organizations and to generate diversified growth outside Novant's core hospital operations. It is led by a president at the executive vice president level with a dedicated chief operating officer and general manager. Novant Health has also participated in digital health venture rounds alongside other systems.

Novant Health opened its Institute of Innovation & Artificial Intelligence in Winston-Salem, North Carolina on June 5, 2019 to apply AI to personalized patient care across prediction, prevention, diagnosis and treatment. The institute's purpose is to turn Novant's clinical and operational data into actionable insight at the point of care. Its staffing model mixes full-time institute employees with Novant clinicians and operational leaders who rotate through as subject matter experts on specific problems, so solutions are built with the specialties that will use them. The institute is jointly overseen by Novant's chief medical officer and chief digital and technology officer functions. It engages outside technology companies, research organizations, universities and other health care organizations as development partners, selecting vendors to co-develop clinical and operational AI solutions deployed across the Novant footprint.

The NYU Langone Health Venture Fund is a strategic seed-stage investment program operated through Technology Opportunities & Ventures, the commercialization office serving NYU and NYU Langone Health. The fund invests in biomedical startups that use technologies and intellectual property developed at NYU, including drugs, diagnostics, medical devices, and health technology. Official criteria emphasize a significant unmet need, scientific or clinical validation, a viable business model, and a settled intellectual-property position. Beyond capital, the program describes access to business-development support and a network of medical and industry experts, placing the fund within a broader pathway for licensing, startup formation, and commercialization.

The Center for Healthcare Innovation and Delivery Science is NYU Langone Health's center for redesigning and evaluating care delivery, affiliated with the Division of Healthcare Delivery Science in the Department of Population Health. Its mission is to improve patient health and wellbeing by fostering effective, efficient and patient-centered healthcare systems. CHIDS works through five integrated approaches: designing healthcare delivery redesign interventions, evaluating interventions already deployed across the health system, applying digital design and clinical informatics methods, deploying predictive analytics and artificial intelligence, and conducting health policy research. Its staff includes clinicians, researchers, educators and administrators who partner with operational leaders across NYU Langone. The center is one of the institutional pillars of NYU Langone's Health Tech Hub, and it collaborates with external researchers and technology partners on digital tools and large federally funded studies.

The Health Tech Hub is NYU Langone Health's centralized resource for internal and external digital health innovators, launched in 2017. Its stated mission is to drive patient-centered, high-quality care through the development and application of digital health innovations and technologies. The Hub coordinates five programs: Health Tech Connect, which provides co-development and mentorship to digital health industry partners and startups; FuturePractice, which builds digital tools with NYU researchers; the Division of Applied AI Technologies, which translates predictive models into clinical practice; the Institute for Innovations in Medical Education; and the Center for Healthcare Innovation and Delivery Science. It is supported by the MCIT clinical informatics organization as its clinical IT backbone. Outside companies engage primarily through Health Tech Connect, which offers structured co-development and mentorship inside NYU Langone's digital health ecosystem.

Technology Opportunities & Ventures is the combined technology commercialization unit serving NYU Langone Health and all New York University campuses, colleges and schools. TOV evaluates, protects and manages the institution's intellectual property and moves discoveries to market through licensing partnerships, corporate research collaborations and new company formation. It runs internal funding programs for innovators to advance early-stage technologies toward commercial readiness. TOV also operates a public licensing portal for industry partners seeking access to NYU and NYU Langone technologies.

innovationOchsner (iO) is a named Ochsner Health innovation lab that the official program page says was founded by Ochsner Health in 2015. Ochsner describes iO as combining the roles of a think tank, innovation lab, and health-care technology company, with work focused on improving health, lowering costs, and enhancing patient and caregiver experiences. The public materials describe digital health, advanced analytics, personalized medicine, new treatment options, predictive models, and data-enabled care as areas of work. The iO work page names connected programs and capabilities including Connected MOM, Optimal Hospital, Population Genomic Screening, Anatomical Modeling, Predictive Modeling, O Bar, and Clinical Trial Innovation. The home page also states that iO works with organizations inside and outside the industry to invest in and invent the future. This profile records the public innovation structure and collaborations language without inferring ownership, revenue, adoption, or performance.

Ochsner Ventures is the corporate development and investment arm of Ochsner Health, the largest nonprofit health system in Louisiana, formally established in 2022. It operates across three pillars: strategic investments in venture funds and operating companies, development of diversified businesses that support the system's nonprofit mission, and partnerships with national organizations. In 2023 it launched the Ochsner Louisiana Innovation Fund, a $10 million vehicle for seed and Series A companies headquartered or substantially operating in Louisiana, capitalized in part through Louisiana Economic Development's State Small Business Credit Initiative allocation. Investment priorities are value-based care acceleration, digital care delivery and community health access. It both invests and builds businesses, and it works alongside innovationOchsner (iO), the system's internal innovation lab.

OhioHealth New Ventures and Business Incubation is the system department responsible for identifying emerging health care opportunities, adopting outside innovations and backing new ventures. It works across four connected areas: disruption and innovation evaluation, adoption and co-development with external partners, strategic venture investment in later-stage companies, and concept and seed-stage incubation for OhioHealth's own employee innovators. For startups, NVBI acts as a shepherd that makes it easier for third-party entrepreneurial companies to get their product adopted and piloted inside OhioHealth. Internal inventors get market feasibility assessment and introductions to a partner network, and outside companies submit proposals through a formal submissions process.

OHSU Technology Transfer, operating under the OHSU Innovates umbrella, assesses the commercial potential of research and collaborative ideas, protects intellectual property, and promotes licensable technologies to industry. The office negotiates license and option agreements and bridges funding gaps for promising innovations through commercialization grant programs. It provides step-by-step support for faculty and clinicians launching OHSU startups, including startup formation resources and equity/licensing terms. OHSU Innovates publishes annual reports and performance data on its commercialization activity.

Orlando Health Strategic Innovations is the health system's division for inspiring and accelerating innovation across the enterprise, bringing proven clinical innovations and technological advances to market and creating new revenue streams through partnerships and investments. It has three main components. The Foundry is an internal accelerator that identifies, refines and commercializes ideas from Orlando Health team members and physicians, covering software, apps, medical products and regulated devices. Orlando Health Ventures is the corporate investment arm, providing financial, operational and strategic support to companies whose technology can improve patient outcomes and change care delivery. The Center for Innovation is a physical hub on South Division Avenue in Orlando with flexible meeting space, a 3D printing lab and a prototyping workshop, and outside companies engage the division through venture investment, pilots and co-development with its clinical and engineering staff.

OSF Innovation is the enterprise innovation function of OSF HealthCare, combining multidisciplinary internal teams with external partners to identify, develop and implement healthcare solutions. It operates the Jump Trading Simulation and Education Center, a large simulation and clinical training facility, alongside internal development and validation programs. Its venture arm, OSF Ventures, invests in early-stage healthcare companies. OSF Innovation also partners with external accelerators including AVIA, Dreamit, gener8tor, Matter and MassChallenge to source and pilot startup technologies.

OSF Ventures is the venture investment arm of OSF HealthCare and sits inside OSF Innovation, the system's broader innovation organization. It makes post-seed direct investments as part of syndicates in health IT, medical devices, therapeutics, diagnostics and technology-enabled care delivery, and it also commits capital to third-party healthcare venture funds. Its third and largest fund launched in January 2022 at $100 million, bringing total assets under management to roughly $250 million across three funds. The team pairs capital with access to OSF's hospitals for piloting and validation, and it has screened close to 1,500 opportunities since the program began. It invests rather than incubating companies itself, although OSF Innovation runs adjacent accelerator and internal-innovation programs.

OSF HealthCare runs a dedicated Nursing Innovation Lab inside OSF Innovation that develops nurse-led solutions to improve care delivery and nursing workflow. Alongside the lab, OSF launched a Nursing Innovation Fellowship in 2024 for experienced bedside nurses, who continue working two clinical shifts a week while spending the rest of their time on innovation and education work. Fellows are selected through a competitive process requiring four to five years of experience, documented outcomes, a 1,000-word essay, a CNO recommendation and a panel interview, and each is paired with a mentor. The program deliberately builds peer coaches rather than concentrating innovation among executives, on the theory that peers are the most powerful influencers at the point of care. Lab projects include a partnership with the University of Illinois on detecting and mitigating early signs of nurse burnout and intent to leave.

PCCI is a mission-driven nonprofit research and development organization that began as a department inside Parkland Health and was spun out as an independent entity in 2012. It specializes in practical applications of artificial intelligence and non-medical drivers of health for underserved populations, deploying predictive models for population health and clinical decision support. Its products include the Community Vulnerability Compass for social risk analytics and the Isthmus data integration platform for digital health infrastructure. PCCI remains tightly connected to Parkland Health, the Parkland Foundation and the Parkland Community Health Plan while working with other health systems and payers across North Texas and nationally. Outside organizations engage through partnerships that deploy PCCI's clinically validated AI models in their own settings.

The Mirro Center is Parkview Health's dedicated research and innovation facility, combining clinical research, informatics research, precision health, a medical simulation lab and an innovation team under one roof. Its innovation arm runs an annual global innovation competition on a rotating clinical theme, awarding cash prizes plus entry into an accelerator program and connections to Parkview clinicians for solution validation. In October 2025 Parkview opened a satellite innovation office in a startup garage bay at the 16 Tech Innovation District in Indianapolis, with drop-in hours for entrepreneurs. Outside startups engage the center for industry connections, research collaboration and product testing in a real clinical environment, and the center has partnered with the University of Notre Dame and the 1842 Fund on rural health challenges.

Penn Medicine's Center for Health Care Innovation publishes the Innovation Accelerator Program (IAP) as a structured pathway for faculty and staff developing, testing, and implementing new approaches to health-care delivery and patient outcomes. The official program page describes multiple phases: early testing and evidence generation, additional development and scaling, operationalization with sustainable infrastructure, and, when appropriate, support for other health systems to adopt successful innovations. The program includes workshops, innovation-advisor mentorship, project funding, leadership review, stakeholder support, and business-model planning. Penn's page says the program has funded more than 30 projects since inception, but this profile does not interpret that figure as a success rate or commercial outcome. The profile focuses on the documented internal innovation and implementation model rather than assuming a separate licensing or investment route.

Penn Medicine's Innovation Accelerator Program supports faculty physicians and staff who want to design, test and scale new approaches to healthcare delivery. Teams move through four defined phases: Phase One over six months validates that an idea might work, with training, mentorship and up to $10,000; Phase Two over up to a year proves the idea does work at larger scale with up to $50,000; Phase Three operationalizes the intervention across Penn Medicine with sustainable infrastructure; and Phase Four supports adoption by other health systems. The program is run out of the Center for Health Care Transformation and Innovation and pairs clinical teams with designers, data scientists and implementation staff. Proposal calls run every one to two years.

Penn Health-Tech is a University of Pennsylvania center, established around 2017, that connects innovators across Penn Medicine and Penn's engineering and business schools to advance medical devices and healthcare technology. Its core vehicle is the Health Tech Accelerator, which runs annual cohorts of faculty and clinician teams and provides project funding, advising and commercialization resources. It also runs the ELITE Fellowship with Venture Lab, faculty salons, a speaker series and office hours for prospective inventors. Recent cohorts have included eleven teams in 2024, eight in 2025 and six in 2026. It funds and accelerates internal projects rather than making external venture investments.

The Center for Medical Innovation supports Penn State College of Medicine faculty, researchers and learners in moving medical innovations toward commercialization. It works through three service lines: agreements, which safeguard publication rights and intellectual property; innovation education, which provides entrepreneurial training, stakeholder engagement strategy and commercialization guidance; and innovation project support, which supplies seed funding, technology development expertise, business strategy and industry connections. Its two named programs are the Innovation Fellowship, a competitive 12-month non-clinical fellowship for medical students, postdoctoral researchers and graduate students that funds departments so fellows get dedicated innovation time, and the Pathways Program for faculty. Fellowship components include workshops, coaching from innovation staff, industry mentorship, I-Corps customer discovery training and investor pitch preparation. Outside companies engage as industry mentors, licensees and investors through the center's connections.

The Office of Nursing Research and Innovation at Penn State Health Milton S. Hershey Medical Center develops research and evidence-based practice activity intended to promote innovations in patient care delivery. Its stated responsibilities include building mentorship systems so nursing staff can create practice innovations, and collaborating with academic departments on joint research initiatives. The office is led by a director who previously created the Department of Nursing's Evidence-based Practice Fellowship and Writing Academy, both of which channel staff-generated ideas into evidence-based projects and publications. It serves bedside and advanced practice nurses across the medical center rather than external companies, and connects them to academic research partners at Penn State. Public information on the office comes from Penn State's announcement of its director.

The Innovation Maturation Fund is a joint translational funding vehicle created in 2019 by Prisma Health, South Carolina's largest nonprofit health system, and Clemson University through the Health Sciences Center partnership and the Clemson University Research Foundation. It awards up to $200,000 per year in grants to move health-focused technologies from research toward commercial viability, and was described at launch as the first such fund targeted exclusively at health sciences researchers. Eligible applicants include Prisma Health clinicians, Clemson research faculty and graduate students, which deliberately pairs clinical problem definition with engineering capability. Stated goals include advancing medical technologies, supporting translational research, creating jobs and driving regional economic growth. It funds and matures technologies rather than making equity venture investments.

Providence launched Providence Ventures in 2015 to invest in and build digital health companies aligned with the system's operating priorities, and in January 2025 the team spun out as an independent firm named Allumia Ventures. Providence committed $150 million to the spun-out third fund over ten years, following two prior $150 million funds, and Allumia is inviting other health systems in as strategic limited partners. Beyond investing, the group functioned as a company builder for Providence, incubating and spinning out operating businesses such as Xealth, DexCare and Praia Health. The firm invests in tech-driven healthcare companies across care delivery, patient access and clinician workflow. It has a documented exit record that is unusually deep for a provider-sponsored fund.

The Providence Institute for Clinical Innovation, presented publicly as the Providence Innovation Institute, is an innovation function operating within Providence's health-system network. Its official site says the institute transforms care breakthroughs into standard care by combining scientific rigor, a broad clinical network, and community connections, with validation, implementation, and equitable scaling as stated parts of its approach. The site names programs including Providence Discover, Providence Genomics, the Health Research Accelerator, and Providence ADVANCE. The ADVANCE Program for Startups is described as a front door into Providence for startups and innovators, with access to experts, data, research infrastructure, and care settings for development, testing, validation, and potential scaling. This profile records the institute's stated research, implementation, and startup-collaboration model without assuming that a participating solution was adopted, sold, licensed, or successful.

The Digital Innovation Group is Providence's internal venture studio, building and commercializing new digital health companies from inside the health system rather than investing in outside startups. It uses an inside-out model: it identifies problems raised by patients, caregivers and other health systems, writes business plans for the most promising ones, then develops, tests and refines the product inside Providence's own clinical operations before scaling it to external customers. The group's advantage is access to Providence's data, clinical expertise and real workflows, which external startups typically lack. Companies that mature are spun out as independent, venture-backed entities that sell to health systems nationwide, and outside investors and health system customers engage at that stage. It serves Providence clinicians and operators as the source of ideas and outside health systems as customers.

The Renown Institute for Health Innovation is a joint institute of Renown Health and the Desert Research Institute that integrates personal health data, environmental data and socioeconomic factors to address Nevada's health challenges. Its flagship effort is the Healthy Nevada Project, a population health and genomics study that returns clinical genetic results to participating volunteers, including risk information for heart disease and certain cancers. The institute uses the study cohort to expand access to clinical trials for northern Nevada residents and to build research connections with biotechnology and pharmaceutical companies. Outside companies engage as research and commercial collaborators on the cohort; reported partners have included Helix, Gilead Sciences and Siemens Healthineers. The institute has also built public-facing tools such as DANA, a life-sized holographic AI avatar that educates the public about genetic testing.

IdeaLab is a partnership between Rochester Regional Health and the Albert J. Simone Center for Innovation and Entrepreneurship at Rochester Institute of Technology. Twice a year, in spring and fall, the two organizations run a two-day intensive event in which multidisciplinary RIT student and faculty teams tackle four to six real clinical and operational challenges submitted by Rochester Regional Health. Teams brainstorm, design and build prototypes under the guidance of RIT faculty and Rochester Regional clinical sponsors, then present solutions on the second day. Promising concepts can advance into further research and product development. Outside companies engage as manufacturing and development partners that take IdeaLab concepts to market.

The Innovation + Technology Commercialization (ITeC) Office sits within RUSH Legal and is responsible for protecting and managing intellectual property generated through Rush University research. It advises faculty, staff and students on invention disclosure, patent prosecution, copyright and material transfer, and it negotiates licenses that move Rush discoveries toward commercial use. The office serves investigators across Rush University Medical Center, Rush University and the wider Rush system, and is the front door for companies seeking to license Rush IP or structure sponsored-research and industry agreements. A small staff of counsel, a technology transfer manager and a paralegal handles the full disclosure-to-license pipeline.

The Center for Innovation opened on September 16, 2022 on the main campus of Robert Wood Johnson University Hospital in New Brunswick as a partnership between RWJUH and Rutgers Robert Wood Johnson Medical School. It brings clinicians, researchers and private industry together to invent and develop new technologies aimed at both complex and common health care problems. Its principal method is designing and running clinical trials that evaluate promising digital health tools in real patients, including wearable sensors, remote robotic ultrasound systems and mobile EKG technology. A digital transformation core team supplies the AI and data science capability behind those studies. Outside companies engage the center by bringing their digital health products into these investigator-led trials and academic partnerships rather than through an investment vehicle.

Sanford Innovation and Commercialization is the innovation office of Sanford Health, the large rural health system serving the Upper Midwest. Its model starts by engaging Sanford employees to surface the system's biggest operational and clinical challenges, then identifies providers and companies across the industry to bring forward solutions. The team helps internal inventors develop technology and license intellectual property, evaluates external partnerships and business collaborations, and provides regulatory guidance including on FDA approval pathways. It runs crowdsourcing challenges and supports frontline staff in translating workflow barriers into product development opportunities. It publishes available early-stage technologies through a public Flintbox licensing portfolio rather than operating an external venture fund.

The Scripps Research Translational Institute, founded in 2007 as the Scripps Translational Science Institute, works to individualize healthcare by combining human genomics with digital technologies and artificial intelligence. Its research spans genomics, digital medicine and clinical-translational science, and it trains translational researchers through NIH-funded programs. The institute leads key components of the NIH All of Us Research Program. It has generated widely cited work on consumer wearables, digital biomarkers and AI-based risk detection.

The Office of Innovation and New Ventures is Seattle Children's technology transfer and venture arm, partnering with the hospital's researchers, clinicians and staff innovators to move pediatric discoveries toward products and treatments. It describes itself as a multidisciplinary team of licensing, patent and venture experts that evaluates and protects intellectual property, then transfers it to market through licensing or new company formation. Outside companies engage the office through licensing deals, sponsored collaborations and industry partnerships, and it maintains a listing of past and current commercial partners. The office also supports inventors through the Intellectual Property Core and a phased technology commercialization grant program run with the Washington Research Foundation. Inventors reach the group through a single intake address for invention disclosures and partnering inquiries.

The Sharp Prebys Innovation and Education Center is a 70,000-square-foot, four-story facility at Sharp HealthCare's Kearny Mesa headquarters campus built to advance research, training, workforce development, innovation, education and technology across the system. It houses the James S. Brown Simulation Center for interprofessional clinical team training, the Cox Technology Immersion Lab for research and technology demonstrations, and the Terrence and Barbara Caster Institute for Nursing Excellence. The simulation spaces let nurses, physicians and interprofessional teams rehearse and refine care processes to improve clinical competence and patient outcomes. The center serves Sharp's own caregivers, including roughly 6,800 nurses, and extends hands-on and virtual training to partner health care organizations and the broader San Diego community. It also includes a 375-seat auditorium and conference space used for community and industry convenings.

Stanford Emergency Medicine's Innovation and Design Advanced Mentorship trains board-eligible or board-certified emergency physicians across three pillars: biodesign, design thinking and digital health. The curriculum combines didactic work in design thinking and biodesign courses with experiential digital health projects and clinical practice. Participants work eight shifts a month, roughly 15 hours a week, as attending physicians in the Stanford University Hospital emergency department, a Level 1 adult and pediatric trauma center, supervising residents and medical students. The program is aimed at physicians with a demonstrated interest in health design, medtech and digital health, and its stated outcome is preparing graduates to advise startups, launch medtech careers, invest or consult in life sciences, and drive health system innovation. Applicants submit a CV, cover letter and clinical and non-clinical letters of recommendation.

Stanford Medicine's Mussallem Center for Biodesign is a named health-technology innovation center with programs that teach a need-driven process for identifying health needs, inventing technologies, and moving solutions toward patient care. The center's official program pages describe offerings for aspiring and experienced innovators, including executive education, fellowships, and other training programs. Its Innovation Fellowship is a 10-month experience covering need finding, invention, and preparation to implement health technologies through start-ups, corporations, or other channels. The published description names medical devices, diagnostics, digital health, drug delivery, and biotechnology among the kinds of solutions fellows may develop. This profile records the center's documented education and company-creation pathways without inferring the commercial performance of any fellow, project, or company.

Stanford Medicine Catalyst is a joint strategic effort of the Stanford School of Medicine, Stanford Health Care and Stanford Medicine Children's Health that acts as the institutional hub for Stanford health care innovations. It funds and incubates promising projects from Stanford faculty, staff, clinicians and students, providing capital of up to $1 million per project along with operational support, mentorship, regulatory guidance and intellectual property support. Projects must be beyond pure concept, typically with an early working prototype or feasibility data, and applications are reviewed by the Catalyst team plus outside industry entrepreneurs and investors through successive evaluation stages. Outside companies and investors engage as reviewers, mentors and downstream partners, since Catalyst expects projects to translate onward through incorporation, investor funding, industry partnerships, licensing or clinical integration. IP protection is handled with Stanford's Office of Technology Licensing.

The Stanford Mussallem Center for Biodesign (formerly the Byers Center for Biodesign) runs the field-defining Biodesign Innovation Fellowship, a nearly year-long, full-time, multidisciplinary program in which physicians, engineers, designers and business people work in teams on health-technology projects. Fellows are trained in the identify-invent-implement Biodesign process: clinical immersion to observe unmet needs, needs filtering, concept generation, prototyping, IP and regulatory strategy, reimbursement planning and business model development. The center also runs a separate eight-month, part-time Biodesign Faculty Fellowship aimed at Stanford faculty with entrepreneurial ambitions, plus global fellowship programs. Faculty mentorship comes from practicing clinician-inventors and medtech industry veterans, and the curriculum has been exported to biodesign programs worldwide.

The Center for Biotechnology is Stony Brook University's biomedical commercialization center and a designated Empire State Development Center for Advanced Technology, housed in the Bioengineering Building on campus. It describes itself as a catalyst for the development of new biomedical technologies and emerging companies, bridging discovery and commercialization while training future biomedical leaders. Its work is organized into business development, technology development, workforce development and infrastructure development programs. The center operates the Long Island Bioscience Hub, the Long Island BioMentor Initiative and a BARDA DRIVe accelerator, which provide translational funding, mentoring and technical support to academic and clinical inventors across Long Island institutions including Stony Brook Medicine. Outside companies and startups engage through these accelerator and mentoring programs and through partnerships on funded technology development projects.

Intellectual Property Partners is the technology transfer office for Stony Brook University, including the researchers and clinicians of Stony Brook Medicine. The office manages invention disclosures, patent filings, licensing agreements, confidentiality agreements and material transfer agreements on behalf of university and medical inventors. It also supports new venture creation through programs such as Brook & Beyond and the campus NSF I-Corps site, helping faculty and student teams test commercial hypotheses and spin out companies. IPP markets available technologies to industry and negotiates the resulting license and option agreements. Companies engage by licensing Stony Brook intellectual property, sponsoring research, or partnering with faculty spinouts such as the quantum communications company Qunnect.

The Office of Technology Transfer at SUNY Upstate Medical University facilitates commercialization of healthcare and biomedical research innovations in support of Upstate's mission to improve community health. It manages intellectual property, commercialization and business development operations for the medical university and tracks the resulting economic impact. The office works with faculty inventors on disclosures, patenting and licensing, and markets Upstate technologies to industry partners. It connects faculty to related regional resources including the Upstate HealthTech Pilot Fund and the Innovate Upstate collaborative research network. Companies engage through licensing of Upstate technologies, sponsored and collaborative research, and industry research agreements.

The Sutter Health Innovation Center is a hub where technology partners, leaders, clinicians and employees collaborate on new care models and digital health products. It includes a simulation lab for piloting healthcare advancements, clinician training space, and programming for innovation events and partner development. Its strategic focus areas include streamlining clinician workflows, expanding digital consumer engagement and access, redesigning care delivery, and building a digital partner ecosystem. Sutter also runs an internal innovation challenge that has surfaced employee-generated digital care solutions.

Tampa General Hospital launched InnoVentures in the first quarter of 2021 as the academic medical center's venture capital fund, now branded TGH Ventures. The program was built on three vehicles: the TGH Innovation Lab for internal operational improvement, the TGH Accelerator for early-stage healthcare companies, and direct venture investments in healthcare and healthcare-adjacent companies. It is housed with Embarc Collective in a 32,000-square-foot facility in Tampa's emerging medical district. Complementary programs include Co-Lab, which provides entrepreneurial resources, and IdeaHQ, which crowdsources ideas from team members. It both invests in and accelerates outside companies while developing internal ideas.

Temple University's Office of Technology Commercialization and Business Development is the integrated hub through which entrepreneurs and industry find partnership opportunities in Temple research, including work from the Lewis Katz School of Medicine and Temple Health. The office runs the invention disclosure process for Temple researchers, evaluates and protects intellectual property, and negotiates licenses and industry contracts. It also operates an active startup program aimed at accelerating technology development and forming new spinout companies around Temple discoveries. Its publicly marketed pipeline spans drug delivery microspheres, catheter-based therapies, wound healing materials, rehabilitation technology and therapeutics for a range of diseases, alongside non-medical technologies such as battery materials. Outside companies engage the office as licensees, sponsored-research partners and investors in Temple spinouts.

The Center for Nursing Research, Innovation and Quality is Texas Children's Hospital's infrastructure for clinical inquiry by nurses, described by the hospital as the means to advance the frontier of nursing knowledge and improve practice and patient outcomes. NRIQ provides education, consultation and mentorship to clinical nurses running research studies, evidence-based practice projects and quality improvement work. It administers the Mary Jo and David Andre Research Grants, which fund original clinical research and quality improvement projects proposed by staff nurses. The center hosts Nursing Grand Rounds throughout the year to showcase nurse scholars' work and supports the Evidence Based Practice and Research shared governance council. Nurse scientists and nurse executives staff the center and are individually reachable by email.

TMC Innovation is the startup acceleration and venture arm of the Texas Medical Center, uniting innovators with scientists and clinicians at TMC member institutions. It runs cohort-based accelerator programs including HealthTech (formerly TMCx), the Accelerator for Cancer Medical Devices (ACMD) and the Accelerator for Cancer Therapeutics (ACT). TMCi forms, fosters, recruits and funds healthcare companies globally, providing lab and office space, mentorship and access to TMC clinical partners. It also operates a Biodesign fellowship that spins out new medical device companies.

TMC Biodesign is a full-time, paid fellowship run by the Texas Medical Center Innovation Institute that assembles multidisciplinary teams of clinicians, engineers and business people to build healthcare startups. Fellows work through the identify-invent-implement innovation process, beginning with clinical immersion across TMC member institutions such as MD Anderson, Baylor College of Medicine and Texas Children's Hospital. The program supplies stipends and health benefits, prototyping funding, access to Medical Device Labs @ TMC, seed funding for startup formation, and workspace inside the TMC Innovation Factory. Originally focused on medical devices and digital health, the fellowship has since expanded to additional health technology categories, and teams graduate as incorporated companies rather than as projects.

The Population Health Innovation Institute is MetroHealth's internal engine for designing, testing and scaling value-based care delivery models for a largely safety-net population. It works across three pillars: people (patients, providers and community professionals), data and knowledge (measuring and optimizing care delivery), and relationships (internal experts plus external partners across Northeast Ohio and nationally). The institute focuses on high-risk elderly, chronically ill and uninsured or underinsured residents of Cuyahoga County, and it builds programs such as Red Carpet Care transitions and MetroHealth CarePlus coverage. It partners with payers, community organizations and outside collaborators to pilot and evaluate new care and payment models.

Ohio State's Enterprise for Research, Innovation and Knowledge (ERIK) houses the university's Technology Commercialization Office and corporate engagement functions, serving Wexner Medical Center researchers among others. ERIK manages research administration, compliance, IP commercialization and industry partnerships. Its commercialization arm licenses technology through the Ohio State Innovation Foundation and supports faculty startup formation. Ohio State is a signatory of the Ohio IP Promise, a standardized framework for faculty commercialization terms.

The Innovation Fellowship is a 12-month interdisciplinary program run by the Center for Healthcare Innovation and Leadership at the Ohio State University College of Nursing, which exists to bring together leaders in innovation, entrepreneurship, education, practice and research. Fellows advance a real project through three phases the program calls creative inquiry, design and development, and synthesis and spread, with personalized coaching and a peer cohort. Participants identify high-leverage problems, prototype solutions, and finish with deliverables ready for launch, publication or scaling. The fellowship is open beyond Ohio State: the 2025-26 cohort includes faculty and healthcare professionals from a range of institutions and disciplines. An external advisory board of innovation and entrepreneurship practitioners supports the cohort.

The Ohio State Innovation Studio is an interprofessional maker and venture space founded inside the College of Nursing that brings students, faculty and staff together to build healthcare products, services and software. It is equipped with prototyping tools including 3D printers and laser cutters, and provides mentorship, technical support and an ambassador program. Interprofessional teams compete for seed funding through the Innovation Showcase, and funded teams can return for additional grant cycles to advance their innovations. Ohio State Wexner Medical Center employees are eligible to participate, extending the studio beyond the academic campus into the health system. The studio was created through a gift from Connie Hahn Sharpe and Gary Sharpe, founders of Health Care Logistics, Inc.

The University of Kansas Health System's Department of Innovation works with frontline clinical staff, including bedside and perioperative nurses, to develop and commercialize their ideas. The department manages the innovation pipeline end to end, coordinating patent filing, market research, user surveys, product development and prototype testing on behalf of the employee who had the idea. Its system director for digital strategy and innovation has described the model as deliberately tapping simple frontline ideas, and the health system shares commercialization success with the staff member who originated the concept. The department is internally facing but works with outside product development and patent resources to move concepts toward market. Its work with nurses has been documented by the American Nurses Association's innovation blog.

The Digital Health Co/Lab, formerly the Center for Health Innovation and Transformative Care, is a joint effort of KU Medical Center, The University of Kansas Health System and the University of Kansas focused on digital health research and commercialization. Its work is organized around three AI-anchored domains: enabled devices, digital therapeutics and diagnostics, and tech-centric providers. The Co/Lab is guided by an Innovation Advisory Board and connects clinicians and researchers with industry partners to move digital health solutions toward patients and providers. It runs an annual Innovators Day featuring keynotes, panels and networking that brings outside companies, investors and clinicians together.

KUCTC is the single technology commercialization office serving all University of Kansas campuses, including the KU Medical Center campus that anchors The University of Kansas Health System. It identifies and protects intellectual property, prosecutes patents, and negotiates licenses for KU inventions, including clinical and biomedical technologies. The office works as a one-university operation with staff at KU Innovation Park in Lawrence and at Fairway North on the KU Medical Center campus in Kansas City. It partners with the surrounding innovation ecosystem, including KU Innovation Park and the Institute for Advancing Medical Innovation, to support startups and industry engagement, and publishes annual impact reports.

MD Anderson's Strategic Industry Ventures oversees licensing, commercialization and collaborative partnerships designed to accelerate preclinical and clinical development of diagnostics and therapeutics across multiple modalities. It contains the Office of Technology Commercialization, which handles invention assessment, patent matters and license negotiation. SIV identifies opportunities connecting industry collaborators with MD Anderson technology and expertise and manages alliance operations for those partnerships. The group is a named example in Becker's list of hospitals with innovation programs.

Trinity Health Innovation is the multi-state Catholic system's central innovation program, organized around a "People-Centered Care" strategy and a goal of leading in community health improvement. It runs a portfolio of mechanisms rather than a single lab: Innovation Challenges that solicit ideas from colleagues, Innovation Campaigns and pilots, Innovation Cohorts, a Rapid Design Incubator, innovation events, and a venture capital investment portfolio. The program deliberately prioritizes innovations that keep people well and that serve vulnerable populations across Trinity Health's communities. It serves Trinity Health colleagues and ministries, and connects them with outside solutions and pilot partners through its campaigns and cohorts. The program maintains a dedicated internal-facing site describing each of these tracks.

Tufts Technology Commercialization, part of the Office of the Vice Provost for Research, is the technology transfer and industry collaboration office that handles inventions from Tufts Medical Center as well as Tufts University schools. It evaluates disclosures, manages patenting, markets available technologies and negotiates licenses and industry research agreements. The office maintains a searchable portfolio of technologies available for licensing, including Tufts Medical Center inventions in areas such as immunoglobulin RNAi therapies, orthopedic devices, neuromuscular treatments and vascular imaging. Licensing officers are assigned by school, with a dedicated point of contact for Tufts Medical Center technologies. Outside companies engage by licensing listed technologies, sponsoring research, or contacting the office about assets not yet published on the site.

The Bill L. Harbert Institute for Innovation and Entrepreneurship (HIIE) is UAB's central hub for commercializing research from its academic medical center and university, and it houses UAB's technology transfer function through the UAB Research Foundation. HIIE describes its role as fostering an entrepreneurial community and innovation ecosystem at UAB while providing the infrastructure faculty, staff and students need to commercialize their innovations. Services span invention disclosure, intellectual property protection, licensing negotiation, startup formation guidance and connections to research funding. The institute markets a portfolio of available technologies to industry and investors and supports launching sustainable startups built on new or disruptive technologies. Outside companies engage HIIE as licensees of UAB technology, as sponsors of applied research, and as partners in the surrounding Birmingham startup ecosystem.

The UC Davis Health Cloud Innovation Center is a joint effort between UC Davis Health and Amazon Web Services, and was the first AWS Cloud Innovation Center established at an academic medical center. It focuses on digital health equity, bringing clinicians, patients, developers and students together to design and prototype solutions for equitable and accessible digital health. The center operates as an open innovation platform: community members and partner organizations submit real-world challenges, and the center builds proofs of concept against them. All outputs, including working prototypes, are published as open source so other organizations can implement and adapt them. Focus areas include remote patient care equity, bias in AI algorithms, transportation barriers to care and mental health access. It sits within UC Davis Health's Digital CoLab.

UC Davis Health Ventures is the commercialization and venture office for UC Davis Health, created to translate human health research into commercial practice and to build an innovation and entrepreneurship culture across the health system. It develops and commercializes health-related intellectual property, manages translational funding programs, and builds strategic product portfolios out of clinical and biomedical research. The office serves UC Davis Health faculty, clinicians, startups and outside companies seeking to license or partner on UC Davis health technologies. It sits within the university's Innovation and Economic Development Office alongside Venture Catalyst and Aggie Square. With Venture Catalyst it jointly manages the STAIR HEALTH proof-of-concept grant program that funds faculty-led health innovations toward commercial and clinical application.

UCI Beall Applied Innovation is the University of California, Irvine's campus-wide innovation and commercialization hub, serving faculty, clinicians and student innovators across UCI including UCI Health and the School of Medicine. It is organized into four groups: the Research Translation Group for invention disclosure and technology licensing, the Enterprise Collaborations Group for industry partnerships, the New Ventures Group for startup formation and I-Corps training, and the Cove @ UCI, a physical facility with offices, labs and event space. Outside companies engage through licensing, industry-sponsored research agreements and enterprise collaborations, and startups use the Cove for space and mentorship. Its flagship Proof of Product grants fund prototyping, feasibility studies and customer discovery for UCI inventions. Therapeutics and medical devices are among its core focus areas.

The CU Healthcare Innovation Fund is a strategic healthcare venture fund affiliated with the CU Anschutz Medical Campus and backed by UCHealth and Children's Hospital Colorado, giving it access to three clinical enterprises for validation and deployment. It invests primarily in healthcare IT and technology-enabled services, with selective investments in medical devices and pharmaceuticals. The fund reports roughly $100 million in assets under management, having originally closed with $50 million in committed capital. Its management and investment advisory board is drawn from healthcare entrepreneurs and investors, and it maintains strategic relationships with more than ten multinational healthcare corporations. UCHealth separately operates the CARE Innovation Center as its internal innovation function.

The UCHealth CARE Innovation Center is a clinical-validation sandbox founded in 2016 that develops, validates and optimizes next-generation healthcare solutions across the UCHealth system. Its focus areas are data science and AI, digital patient experience, VR and AR, and wearables and virtual health. The center partners with companies to pilot technologies in live clinical environments and operates an Innovation Lab in Denver's River North district alongside its Anschutz Medical Campus base. UCHealth pairs the center with a venture capital fund to invest in the companies it validates.

UCLA Technology Development Group is the campus-wide gateway to innovation, research and entrepreneurship at UCLA, including technologies from the David Geffen School of Medicine and UCLA Health. TDG manages invention disclosure, patenting, licensing and startup creation, and negotiates sponsored research and corporate partnership agreements. It runs entrepreneurship programming and connects faculty founders with investors. TDG publishes annual disclosure and company-engagement metrics.

The UCLA Health Innovation Challenge is an annual competition run by the UCLA Health Office of Innovation that invites faculty, staff, trainees, students, patients, caregivers, volunteers and community members to submit ideas that advance care delivery and health equity. It runs three tracks: Scale Health Equity, which funds projects up to $50,000 and requires a UCLA Health faculty member, at least one UCLA Health RN or staff member and a community partner organization; Invent HealthTech, also up to $50,000, for early-stage medical devices, diagnostics, digital therapeutics and software, requiring a UCLA Health faculty member plus an RN or a faculty member from another UCLA school; and an open Submit Your Greatest Idea track. The requirement that clinical teams include nurses alongside physician faculty makes it an explicitly interprofessional innovation pathway. Winning teams then plug into the Office of Innovation's wider ecosystem, which includes the UCLA Biodesign Fellowship, Biodesign Accelerator Fellows, the NSF I-Corps Innovation Node Los Angeles and external accelerator partners. The 2025 cycle was the fifth annual challenge.

UCLA Biodesign is an early-stage health technology innovation program that runs a year-long, full-time fellowship for interdisciplinary teams drawn from medicine, engineering, design and business. Fellows complete clinical immersion inside UCLA Health, identify and screen unmet needs, build prototypes, and work toward venture formation with mentorship from healthcare leaders and investors. The program provides 24/7 access to creative workspace and equipment, and explicitly welcomes prospective and current first-year residents and clinical fellows who have departmental support, alongside MS/PhD engineers, designers and MBAs. It is housed within UCLA Health's innovation infrastructure and is affiliated with the UCLA Clinical and Translational Science Institute.

The Acute Care Innovation Center in UCSF's Department of Emergency Medicine develops, tests and scales acute care innovations across what it calls an acute care test bed made up of three distinct emergency departments. Its flagship training arm is the one-year EM Innovation Fellowship, which prepares board-certified or board-eligible emergency physicians to lead in healthcare innovation, human-centered design and system improvement. Fellows carry eight eight-hour attending shifts per month at Zuckerberg San Francisco General Hospital while receiving immersive training in human-centered design, clinical informatics, digital health and implementation science, plus protected time for a leadership curriculum and scholarship. Fellows can take an external certificate program such as MIT's Design Thinking Executive Education or the UCSF Health Data Science Certificate, and complete a capstone project with a sustainability plan and a publication goal. The center works with outside partners on projects run through its emergency department test bed.

The Biodevice Innovation Pathway is a dedicated research track within UCSF Surgical Innovations for surgery residents who want to build medical technology. It gives residents one to two years of full-time, hands-on experience developing and translating novel devices for unmet clinical needs, spanning device design and prototyping, animal model development, clinical trial participation, startup formation, and regulatory and business strategy. The pathway is open to UCSF surgery residents and to residents in surgical disciplines at other universities. It is co-directed by a pediatric surgeon and a bioengineering faculty member and draws on more than 15 faculty mentors across surgical specialties and bioengineering. Residents work on translational projects that have progressed toward companies and clinical use, which is also the main way outside investors and industry partners engage.

The Center for Nursing Excellence & Innovation is the UCSF Health Department of Nursing's hub for professional nursing practice, education, leadership and innovation. It houses professional development pathways including orientation, clinical ladder promotion and CPR training, student clinical placements, and gerontological nursing programs. CNEI runs a Leadership Institute covering leadership development and evidence-based practice, and administers a Clinical Nursing Research Grant that funds nurse-initiated inquiry. The center also provides continuous improvement and quality analytics support so that nurse-generated practice changes can be measured. It operates from a dedicated facility on The Embarcadero in San Francisco.

UCSF Innovation Ventures publishes a HealthTech Commercialization function for translating discoveries from UCSF clinicians and researchers into products and services. The official page says the team evaluates inventions, develops commercialization and intellectual-property strategies, connects researchers with industry collaborators, facilitates formation of start-ups, and secures licensing deals. A separate UCSF commercialization-process page describes a path from disclosure and assessment through intellectual-property protection, development, partnering, and licensing. The public materials identify health technology broadly rather than limiting the office to one clinical specialty; the page references therapeutics, diagnostics, medical devices, digital health, and platform technologies in the surrounding UCSF innovation program materials. This profile records those stated services and routes without assuming that every disclosed invention reaches a license, company, or market.

The UCSF Rosenman Institute supports healthtech entrepreneurs, including UCSF clinicians, in moving medical device and digital health concepts toward commercialization. Its Rosenman Innovators program selects early-stage companies each year and connects them to a curated network of clinicians, industry experts, corporate partners and investors, while the Rosenman Fellowship supports academic innovators in identifying and validating unmet clinical needs. The institute also runs UCSF Rosenman ADAPT, which pairs startups with large healthcare companies for scaling partnerships, and Rosenman RISE, a mentorship and networking track for underrepresented entrepreneurs. In 2022 the institute partnered with the UCSF Division of Cardiology to fast-track cardiovascular health technology through a dedicated fellowship program.

UF Innovate is the University of Florida's integrated commercialization organization serving UF Health researchers and the wider university, made up of four units: Tech Licensing, Ventures, Pathways and Accelerate. Tech Licensing manages intellectual property, negotiates agreements, guides inventors through technology transfer and assesses whether a discovery should be licensed or spun out. Ventures focuses on startup funding and investment, Pathways provides entrepreneurship training and support, and Accelerate operates UF's incubation programs including The Hub. The office explicitly connects researchers with investors and industry and leads them through the commercialization process from disclosure to deal. Outside companies engage UF Innovate as licensees of UF technology, as industry sponsors, and as tenants and mentors within its incubators.

The Office of Technology Management commercializes research and educational activities at the University of Illinois Chicago, including discoveries from the Colleges of Medicine, Pharmacy, Nursing and Dentistry that sit alongside the UI Health hospital and clinics. Its stated mission is moving ideas from the mind to the marketplace, and it handles invention disclosure, patent development, portfolio management and licensing. OTM negotiates industry partnerships and licensing agreements and runs outreach and education for faculty and students on the commercialization process. It is based on the UIC medical campus on West Polk Street and publishes an annual impact report.

The Elaine Marieb Center for Nursing and Engineering Innovation pioneered what it calls the Nurse-Engineer research approach: bidirectional, real-time collaboration in which nurses identify healthcare challenges and engineers help develop, refine and evaluate solutions. The center maintains a formal academic-clinical partnership with Baystate Medical Center, and its joint projects run inside Baystate's clinical units including the emergency department. It is co-directed by faculty from nursing and mechanical/industrial engineering and awards annual pilot grants for nurse-engineer projects. Its programs include SHINE, an NSF-funded graduate training program for PhD nursing and engineering students. Active projects span IV smart pump flow rate accuracy, chest tube holder design, nursing robotics, warm air therapy polymers and eye-tracking studies of medical device safety.

BRIDGE Innovation and Business Development is UMass Chan Medical School's office for translating faculty discoveries into licensed products and new companies. It runs the BRIDGE Fund, an internal translational funding program that invests in faculty projects with commercialization potential across therapeutics and medical devices, and it manages intellectual property, licensing and industry partnering for the medical school. A dedicated new ventures function supports faculty founders through company formation, and the office hosts pitch events that put emerging UMass Chan companies in front of venture capital firms, corporate venture groups and industry partners. Technology areas span RNA therapeutics, gene editing, AI-enabled surgical tools, immunology, diagnostics and oncology. Outside investors and companies engage through those pitch days, through licensing, and as partners and financiers of UMass Chan spinouts.

UNC Health Ventures is the corporate investment fund for UNC Health. Established in 2012, it describes itself as an entrepreneur-centric strategic investor that combines capital with access to clinical and operating expertise across the UNC Health network. The fund invests across medtech, healthtech, and biotech and primarily focuses on Series A and Series B opportunities while retaining flexibility based on sector dynamics and strategic fit. Its official investment approach emphasizes companies that can benefit from UNC Health's expertise and scale while delivering value to the health system and improving patient care, clinical outcomes, or healthcare delivery. Rex Health Ventures is a legacy name rather than a separate current fund.

generate is an open-access medical technology and learning lab (a hospital makerspace) at UnityPoint Health - St. Luke's Hospital that lets nurses, physicians, other staff, patients and community members turn healthcare ideas into working prototypes. The lab was built as a partnership between UnityPoint Health - Cedar Rapids and MakerHealth, a Boston-based company, and is staffed by a team that includes a biomedical engineer and a nurse who provide hands-on training and mentorship to makers of all experience levels. Users get access to prototyping tools and materials on site rather than handing ideas off to someone else, so the person with the idea builds the solution. Two satellite generate labs operate at Witwer Children's Therapy locations in Cedar Rapids and Hiawatha. Outside engagement runs through the MakerHealth partnership and through community and patient access to the lab.

UnityPoint Health Ventures is the $100 million corporate venture fund launched by UnityPoint Health in 2019 to invest in early-stage healthcare companies that can be deployed across the system's Iowa, Illinois and Wisconsin footprint. The fund targets seed, Series A and Series B rounds with initial checks of roughly $1 million to $3 million. Its stated focus areas are digital therapeutics, health IT, technology-enabled services, medical devices and diagnostics, and it explicitly avoids pharmaceutical, biopharma and drug discovery investments. The fund pairs capital with commercial pilots inside UnityPoint's hospitals and clinics. It is an investor rather than a company-building studio.

UH Ventures is University Hospitals' combined innovation, technology transfer and venture investment organization, which it describes as the front door for innovation at the system. It operates a Living Lab that partners with companies on trials and pilots inside UH facilities, invests in companies that have been validated internally or generated from its own innovation pipeline, and runs a technology commercialization office for employee inventions. Areas of interest include health IT, medical devices, diagnostics, digital therapeutics, wellness and enterprise operations. It also serves an economic development role as an anchor institution in Northeast Ohio, including through the Veale Initiative. The group both invests externally and develops internal caregiver ideas into companies.

BioVentures is the technology transfer and commercialization office for the University of Arkansas for Medical Sciences, managing the intellectual property generated across UAMS's colleges, institutes and clinical enterprise. It handles patent filing, copyright and trademark protection, licensing strategy and agreement negotiation, market analysis and business model development for faculty inventions. BioVentures also supports startup formation directly, offering entrepreneurial guidance, incubator space and introductions to investors, plus help identifying and applying for grant funding. It runs the AR Health Ventures Accelerator (ARHVA), a cohort program that accelerates therapeutic and health-related innovations coming out of UAMS. Outside companies engage BioVentures as licensees, research collaborators and industry partners, and the office additionally provides regulatory and policy guidance and IP education for researchers.

The UAMS Institute for Digital Health & Innovation, formerly the Center for Distance Health, works to eliminate health care disparities in Arkansas and abroad through digital health and health care innovations. It integrates technology across the clinical, educational and research missions of UAMS and operates statewide digital care programs rather than confining itself to pilots. Its programs include HealthNow virtual urgent care by video, the UAMS eLink telehealth network, a 24/7 stroke consultation service for hospitals across Arkansas, and a traumatic brain injury program that trains law enforcement. IDHI also runs learntelehealth.org, the South Central Telehealth Resource Center serving three states, and LearnOnDemand, a continuing education portal. Outside organizations engage IDHI as telehealth network sites, as training and resource-center partners, and as technology vendors supporting its statewide programs.

The UC San Diego Office of Innovation and Commercialization supports commercialization of discoveries from across the campus, including UC San Diego Health and the School of Medicine. OIC provides services spanning invention disclosure, patenting, licensing and startup creation. It works to build an entrepreneurial community connecting researchers with investors and industry partners. The office publishes cumulative metrics on startups, licenses and regional economic impact.

The Polsky Center for Entrepreneurship and Innovation houses both the University of Chicago's technology commercialization function and its startup acceleration programs, including biomedical and health technologies from UChicago Medicine. It manages invention disclosure and IP licensing while running accelerators, incubator space and the Edward L. Kaplan New Venture Challenge. Polsky operates the Polsky Exchange co-working space, the UChicago Science Incubator and a San Francisco satellite. It also administers deep-tech venture programs in partnership with other Midwestern universities.

The UConn Nursing and Engineering Innovation Center pairs nurses, who are positioned to identify healthcare problems, with engineers who can translate those observations into working technology. The center organizes its work around four core areas: research, education, community engagement and technology transfer, explicitly including commercialization of nurse-identified inventions. It is co-directed by faculty from the School of Nursing and the College of Engineering and operates out of UConn Tech Park. Programs include seed grants, an innovation fellowship, senior design projects that pair engineering students with clinical problems, and an annual Innovation Forum. Its stated mission is to advance healthcare, workforce and economic development through interdisciplinary nurse-engineer collaboration.

UI Ventures is the startup and commercialization arm of the University of Iowa Office of Innovation, focused on spinning out companies built on University of Iowa technology, much of it from UI Health Care. Staff evaluate identified clinical needs and technologies, then draw on a network of industry professionals and venture investors to assess market viability, team strength and development stage before advancing a concept toward a company. It serves faculty, staff and graduate students as an internal service, and works with outside entrepreneurs and investors who want to license or build on Iowa technology. The office also runs a Translational Research Incubator and related programs including Nurse Innovators and the Iowa Innovation Leadership Fellows, and is based at the MERGE co-working space in downtown Iowa City.

The Nurse Innovators Program helps nurses and other front-line clinicians across Iowa turn the informal workarounds they invent at the bedside into real, scalable products. Program staff meet with each innovator, assemble a customized materials kit for that specific idea, run ongoing technical check-ins and connect participants to Protostudios for prototype refinement. Innovators typically move through the program in about a year and can compete for funding at an annual Nurse Innovator pitch competition. The program is open to nurses, nursing assistants, nurse practitioners, nurse anesthetists, physical and occupational therapists, respiratory therapists and chaplains statewide, and is staffed by a Nurse Innovator Liaison who is herself a working MICU staff nurse. It has partnered with MakerHealth and is supported by Ewing Marion Kauffman Foundation grant funding.

UM Ventures is the joint commercialization and industry-engagement initiative of the University of Maryland, Baltimore (home of the School of Medicine that staffs the University of Maryland Medical System) and the University of Maryland, College Park. It was established in 2012 by the University System of Maryland Board of Regents and the Governor of Maryland to integrate entrepreneurial programs across the two campuses and advance technology development and new venture creation. UM Ventures manages invention disclosure, IP protection and licensing, and runs a New Ventures Office that launches and supports faculty startups. Under the Center for Maryland Advanced Ventures, created by the 2016 Strategic Partnership Act, it operates The GRID, The Baltimore Fund, the Maryland Momentum Fund, the Fischell Institute for Biomedical Devices and Anchor Ventures. Outside companies engage through licensing, an Entrepreneurs in Residence program staffed by industry contractors, seed grants, loans and equity investments in Maryland-based UM Ventures startups, and named corporate research partnerships.

HiiP is a suite of healthcare innovation support and engagement services housed at the University of Michigan School of Nursing that operates as a support hub for nurse-led innovation. It serves nursing faculty, staff and students who are developing products, services, processes, clinical interventions or educational initiatives. The program works through three functions it calls consulting (market analysis, intellectual property guidance and pathway planning), coaching (mentorship from concept through launch), and connecting (access to collaborators, university resources and funding opportunities). Outside engagement happens by routing nurse innovators to university commercialization resources, external collaborators and funders rather than by running its own fund. Prospective innovators reach the program through a consultation request form.

The Earl E. Bakken Medical Devices Center is the University of Minnesota's interdisciplinary medical device center within the Institute for Engineering in Medicine, drawing faculty from Medicine, Dentistry, Veterinary Medicine, Nursing, Pharmacy and the College of Science and Engineering. Its flagship Innovation Fellows Program is a full-immersion education and product development program in which cohorts of engineers, scientists and clinicians identify unmet clinical needs, brainstorm, prototype and pursue grant funding for new medical devices. Fellows work alongside University experts and professionals from the Medical Alley medtech ecosystem, and can use the Medical School's Anatomy Bequest Program. The center also operates MedWorx, a prototyping service offering 3D printing and scanning, CAD, segmentation, augmented reality and virtualization to clinicians, researchers and industry collaborators.

Technology Commercialization is the University of Minnesota's central office for patenting, licensing and spinning out university research, including the medical and health sciences discoveries that flow from the Medical School and M Health Fairview clinical enterprise. It handles patent protection and IP management for inventors, licenses technology to established companies, and structures corporate research partnerships. A Venture Center forms startups around University technology, supported by the Discovery Launchpad program of mentoring, networking and executives-in-residence, a Software Startup Development Program, an Early Innovation Fund and a Discovery Capital Investment Program. Outside companies engage the office to license technologies, sponsor research or partner with University spinouts.

UNeMed is the technology transfer and commercialization company for the University of Nebraska Medical Center, and it also serves inventors at the University of Nebraska at Omaha and Nebraska Medicine. It evaluates invention disclosures, files and manages patents, and moves technologies out through licensing to industry, sponsored research agreements and new startup formation. UNeMed builds ongoing partnerships with industry leaders rather than transacting one-off licenses, and it runs education programming such as an annual Technology Transfer Boot Camp and an Innovation Awards event for campus inventors. Outside companies engage it directly to license UNMC intellectual property or to sponsor research with UNMC faculty.

UNeTech is a university-supported startup incubator in Omaha that builds companies around inventions coming out of UNMC and the University of Nebraska at Omaha. It pairs university technologies, most of which come from the UNMC intellectual property portfolio managed by UNeMed, with community entrepreneurs and operators who can take them to a first customer or a first financing. UNeTech acts as an early investor, taking sweat equity alongside the innovation and connecting founders to local and national investors. It serves faculty inventors, student founders and outside entrepreneurs looking for a technology to build on, and it houses portfolio companies in its Omaha facility.

UNM Rainforest Innovations, formerly STC.UNM, is the technology transfer and economic development arm for the University of New Mexico, including its Health Sciences campus and UNM Health. It protects and commercializes UNM technologies by filing patents and copyrights and transferring them to the marketplace through licensing and startup formation. The organization is a 501(c)(3) nonprofit wholly owned by the UNM Board of Regents and governed by an independent board of directors, which lets it operate with commercial flexibility. It connects businesses, entrepreneurs and investors with UNM-developed technologies, and runs research collaboration grants that pair the Health Sciences campus with the main campus. It is based in the Lobo Rainforest Building in Albuquerque's Innovation District.

Innovate Carolina is the university-wide innovation and entrepreneurship initiative at UNC-Chapel Hill, operating out of the Office of the Vice Chancellor for Innovation, Entrepreneurship and Economic Development. It provides a suite of programs that help faculty, students, staff and local entrepreneurs move ideas into practice, including commercialization support and venture development. The initiative coordinates a cross-university network spanning the schools of medicine, pharmacy, public health and beyond. It also tracks and reports institution-wide technology transfer performance.

The Penn Nursing Innovation Accelerator funds and coaches nurse-originated health care solutions at the earliest stage. Selected students and faculty receive up to $10,000 for research and development, with priority given to ideas serving populations of greatest need. Awardees are mentored by Penn's innovation team and participate in a summer accelerator program based at the Pennovation Center, Penn's translation and commercialization campus. Selection runs through a multi-round competitive process emphasizing entrepreneurial curriculum and business model development. The accelerator sits within Penn Nursing's broader innovation portfolio, which also includes the Eidos LGBTQ+ Health Initiative and Penn4C, a co-creation collaboratory run with Penn Engineering.

The Johnson & Johnson Nurse Innovation Fellowship is a one-year, team-based fellowship for chief nursing officers, nurse executives and senior nurse leaders drawn from U.S. health systems. Each participating health system sends a two-person team consisting of a CNO or nurse executive plus a senior nurse leader, and the pair works on a shared institutional challenge from their own organization. The curriculum combines human-centered design training delivered by Penn Nursing with business strategy and leadership development from Wharton Executive Education. The program culminates in a final in-person pitch session and implementation of the team's solution inside its home health system. Ten two-person teams are selected annually.

CMTI is the University of Rochester's medical technology innovation center, run through the Department of Biomedical Engineering and located steps from the University of Rochester Medical Center. It trains engineers in customer-focused medical device development through a structured annual cycle: summer clinical rotations in surgical specialties, fall needs assessment and concept development, and spring design refinement with regulatory and intellectual property strategy. Coursework covers medical device design, quality systems and FDA regulations, IP strategy, applied human anatomy for engineers and a clinical practicum. Participants work directly alongside URMC surgeons, accumulating more than 130 hours of surgeon collaboration and operating room observation per cycle. The center works with outside companies and with the university's technology transfer function on sponsored device projects and commercialization pathways for the concepts it generates.

UR Ventures is the technology transfer office for the University of Rochester, including the University of Rochester Medical Center, and is administratively based at URMC. It works with faculty, clinicians and student researchers to evaluate invention disclosures, secure patent protection, market technologies and negotiate licenses with industry. The office also supports researchers who want to form startup companies, providing guidance on company formation and connections to investors and entrepreneurs. Its stated mission is to ensure that University of Rochester innovations enrich the community and improve society. Outside companies engage through licensing of the university's available technologies and through startup partnerships and option agreements.

The University of Utah Technology Licensing Office, formerly branded the PIVOT Center, manages innovation and technology commercialization for the university and University of Utah Health. It handles invention disclosures, patent filings, licensing agreements and startup formation, and connects researchers with industry partners. The office runs the StartUp 360 program to guide faculty founders through company formation. It reports national rankings across disclosure, licensing and license income categories.

The University of Utah Center for Medical Innovation, dedicated in 2026 as the James LeVoy Sorenson Center for Medical Innovation, gives clinicians, residents and students a structured path from clinical need to commercialized device. Its flagship Bench to Bedside competition puts interdisciplinary student and clinician teams through a months-long build-and-pitch cycle that ends with a demonstration of working medical technology prototypes, and Bench to Bedside APEX extends support for the strongest teams. The center also runs fellowship and internship tracks in engineering, regulatory affairs and the Hansen Fellowship, staffed by an in-house engineering and regulatory team. Leadership is drawn from the medical device industry, and the center provides prototyping, regulatory strategy and commercialization guidance directly to University of Utah Health innovators.

CoMotion is the University of Washington's collaborative innovation hub, serving UW Medicine clinicians and researchers alongside the rest of the university. It provides innovation training, IP advising and protection, licensing and material transfer agreements, translational funding and competitions, mentorship, and startup incubation through CoMotion Labs. The organization operates wet-lab and software incubator space in Seattle and supports student innovators. CoMotion reports annual spinoff, licensing and economic impact metrics for Washington State.

WARF is the independent, private foundation that serves as the patenting and licensing organization for the University of Wisconsin-Madison, including biomedical and clinical discoveries from the School of Medicine and Public Health that underpin UW Health. It pays all intellectual property costs for university inventors, prosecutes patents, and licenses technologies to companies worldwide. WARF manages a large investment portfolio and returns tens of millions of dollars a year in grants to UW-Madison and the Morgridge Institute for Research to fund faculty recruitment, fellowships, facilities and new research. Through WARF Ventures it invests directly in Wisconsin entrepreneurs and UW-Madison technology startups, and it engages outside companies through licensing, sponsored research and startup partnerships.

UPMC Enterprises is the official innovation, commercialization, and venture capital arm of UPMC. The About page describes UPMC as a $28 billion health care provider and insurer based in Pittsburgh and states that Enterprises taps more than 5,000 UPMC physicians and the UPMC Health Plan, which it says provides coverage to more than 4 million members. Official materials describe a flexible investment model that supports early- and growth-stage companies and that can also form companies. Two published focus areas are translational sciences, including diagnostics and therapeutics, and digital solutions. Corporate initiatives named on the official site include the Pittsburgh Health Data Alliance with Carnegie Mellon University and the University of Pittsburgh, and the Center for Connected Medicine. Jeanne Cunicelli is publicly identified as President of UPMC Enterprises and Executive Vice President of UPMC. The 2025 annual report states that nine companies joined the portfolio that year and that Enterprises is supporting additional system initiatives, including a real-world data platform called Ahavi and work with UPMC Community and Ambulatory Services.

The Office of Innovation and Strategic Partnerships, which grew out of UT Health San Antonio's Office of Technology Commercialization, supports faculty and researchers in advancing health science innovations from discovery toward commercial impact. It handles invention disclosure and intellectual property protection, advises on commercialization pathways, and manages industry and partnership engagement for the health science center. The office runs a set of education and development programs for clinician and faculty inventors, including Founders Elect, a Commercialization Workshop, an Entrepreneur In-Residence program and IdeaLaunch. Outside companies engage through licensing of UT Health San Antonio technologies, sponsored research and partnership agreements. The office also places student interns into commercialization projects.

TechNovum is UT Health San Antonio's cohort-based accelerator for researcher-entrepreneurs commercializing health-focused innovations. Teams receive commercialization-oriented coaching, structured curriculum, mentoring, business coaching and pitch development, validating product ideas through customer discovery and market research before a Demo Day. The program runs annually with a maximum of eight teams per cohort and charges no participation fee and takes no equity. It is powered by VelocityTX, a nonprofit subsidiary of the Texas Research & Technology Foundation, which supplies mentors, investor connections and access to the VelocityTX Innovation Center. Outside mentors and investors engage as coaches and Demo Day attendees, and graduating teams incorporate as companies.

The UT Southwestern Office for Technology Development protects, enhances and advances UT Southwestern innovations to maximize benefits for community health. It advances research discoveries into commercial technologies, cultivates partnerships with faculty and external partners, and supports both licensing and new company formation. The office is based at Pegasus Park, a Dallas biotech campus, and works alongside UT Southwestern's Innovation Hub. It publishes cumulative metrics on disclosures, patents, licenses, startups and license revenue.

The UTMB Health Technology Commercialization Program is a seed funding initiative that supports and promotes technology transfer and commercialization of UTMB research discoveries. It awards gap funding to develop commercial applications of UTMB-owned technologies, with a preference for proposals that emphasize market opportunity and a clear commercialization strategy. The program is run as a partnership between UTMB's Chief Research Office and its Office of Innovation and Technology Transfer, with the Office of Sponsored Programs distributing funds. It is open to UTMB employees, students, staff and trainees, requires an invention disclosure on file before the pre-proposal deadline, and runs semiannual fall and spring cycles with competitive renewal for projects showing progress. Special consideration goes to interdisciplinary projects involving students from across UTMB's four schools, and funded technologies are then licensed to industry partners through the technology transfer office.

The MakerHealth Space at UTMB's John Sealy Hospital is billed as the first makerspace located inside a hospital, created so that nurses and other front-line staff can design, build and prototype their own solutions at the point of care. It stocks both simple materials such as sewing machines, Velcro and tape and advanced fabrication tools including 3D printers, laser cutters, textiles, electronics and hand and power tools. The space was built with MakerNurse, an initiative that grew out of MIT's Little Devices Lab in 2013 with Robert Wood Johnson Foundation support, and MIT engineers provided technical assistance during setup. UTMB's chief nursing officer led the effort and the space is open to all UTMB staff and students. It has been covered by Popular Science and Medscape as a model for hospital-based nurse making.

The Health Innovation Program is a University of Wisconsin School of Medicine and Public Health center that works to transform health care delivery and improve population health by building research partnerships between UW faculty and health care and community organizations. It provides study design, data and implementation support to investigators and to partner delivery systems, and turns findings into practical, evidence-based tools clinics can adopt. HIP distributes those tools free through HIPxChange, its toolkit platform, on topics such as depression screening, smoking cessation and dementia care. Its partners include UW Health, Marshfield Clinic and the Wisconsin Collaborative for Healthcare Quality, and it also supports career development for faculty, staff and students.

Vanderbilt University Medical Center and Vanderbilt University publish two connected innovation pathways in the health and biomedical research ecosystem. The Medical Innovators Development Program (MIDP) is a four-year MD track that trains physician-innovators through design thinking, clinical immersion, hands-on industry experience, seminars, and courses that take ideas from clinical problems to prototypes and pitch meetings. The official MIDP page identifies a director, associate director, instructors, and a program coordinator. Vanderbilt's Innovation Catalyst Fund provides translational support for projects that need proof of concept or have commercial and social-impact potential; its official page describes expert review, milestone-based funding, prototype development, software development, process improvement, and productization. The fund page also reports facilitated invention disclosures, licensing deals, and startups, but this profile does not interpret those counts as performance or commercial success.

VCU TechTransfer and Ventures, also known as Innovation Gateway, is the office responsible for protecting and commercializing inventions and creations from Virginia Commonwealth University and VCU Health. It holds exclusive authority to license university inventions to established companies and to startups, and it manages the full pipeline from invention disclosure through patenting, marketing and deal negotiation. The office runs a Commercialization Fund that provides gap funding to advance selected VCU technologies toward a licensable stage. It maintains a public technology marketplace organized by discipline, covering biomedical, engineering, software, research tools and arts and education assets. Outside companies engage the office as licensees, option holders and industry research collaborators, and entrepreneurs engage it to form VCU spinouts.

Wake Forest Innovations manages intellectual property for Wake Forest University School of Medicine, the Wake Forest health system and Advocate Health, and its stated mission is to turn research into products. It works directly with physician and scientist inventors through a Develop Your Ideas pathway that covers disclosure, IP protection strategy, market assessment, partnering and new company formation, and it maintains a public Technology for License portfolio. The group also runs a Medical Device Accelerator that helps clinician inventors move device concepts into prototypes and commercial partnerships. Its focus areas mirror institutional research strengths in aging and Alzheimer's disease, cancer, cardiovascular disease, diabetes and metabolism, neurology and neurosurgery, and regenerative medicine, and it is headquartered in Winston-Salem's Innovation Quarter.

The Office of Technology Management is the technology transfer office for Washington University in St. Louis, including the School of Medicine whose clinical enterprise is operated with BJC HealthCare. OTM pairs university research with commercialization expertise to build a pipeline of licensing opportunities, IP-based startups and new ventures. It is located in the Cortex Innovation District alongside the region's startup ecosystem. The office runs a Venture Fellows program placing student researchers in commercialization projects.

The Innovation Fellowship in Weill Cornell Medicine's Department of Emergency Medicine is a one-year, non-ACGME post-graduate program that prepares emergency physicians to work at the intersection of innovation, entrepreneurship and healthcare enterprise. Fellows work 940 clinical hours a year (about 20 hours weekly) with reduced clinical duties from September through November for intensive coursework. The curriculum pairs the Jacobs Institute Runway Program at Cornell Tech, where fellows take startup strategy, customer development and entrepreneurship classes alongside MBA and engineering students, with the department's Healthcare Leadership and Management coursework on ED operations, informatics, coding and billing, compliance and hospital flow. Skills covered include design thinking, regulatory navigation, intellectual property, venture financing and clinical change management, and fellows get quarterly mentorship from emergency medicine leaders and Cornell Tech innovation experts. The program was developed through a partnership between Weill Cornell's Center for Virtual Care and Cornell Tech, which is also how fellows connect to outside startups and investors.

Weill Cornell Medicine's Entrepreneur-in-Residence program embeds experienced entrepreneurs and executives inside the institution to guide Weill Cornell inventors and startup teams through the commercialization process. EiRs are recruited from therapeutics, medical devices, diagnostics, digital health and finance, and they work across the components of Weill Cornell Enterprise Innovation. Their services include one-on-one mentoring on business strategy and business model design, help structuring capitalization, and in some cases stepping into operating roles in the resulting startups. Faculty physicians and scientists with commercializable inventions are the primary users of the program, which sits alongside Enterprise Innovation's licensing and venture activities.

Catalyst by Wellstar describes itself as the first-of-its-kind innovation company and venture firm created by one of the largest health systems in Georgia, combining a corporate venture fund with a physical innovation center in Atlanta. It funds, builds and launches healthcare solutions, investing directly in early-stage companies and then piloting their technology inside Wellstar's hospitals and clinics. Catalyst was launched in 2023 with a $100 million venture fund backed by Wellstar. It also runs Catalyst Voice, a consumer panel of more than 160,000 patients, caregivers and health experts used to test and shape products with real end users. Outside companies engage Catalyst through direct investment, structured pilots within Wellstar, and access to the Catalyst Voice panel and Wellstar clinical mentors.

The WVU Innovation Corporation operates the former Mylan/Viatris research campus in Morgantown as a hub for science, technology, engineering, math and medicine ventures, with the stated aim of creating careers and boosting West Virginia's economy. It facilitates strategic partnerships among academia, industry and community stakeholders and hosts tenant companies alongside WVU's own innovation and commercialization staff. It names WVU Medicine, the 25-hospital health system affiliated with West Virginia University, as a formal partner, along with WVU Corporate Relations and the Morgantown Area Partnership. The Innovation Corporation also connects tenants and outside users to WVU's Shared Research Facilities, which provide access to state-of-the-art instrumentation and expert staff for startups and industry. Outside companies engage it as building tenants, shared-facility users and partners on WVU research collaborations.

West Virginia University created the Office of Innovation and Commercialization in 2024 as a single front door for identifying, protecting and monetizing emerging technologies from across the university, including its health sciences campus and WVU Medicine-affiliated researchers. The office merged what had been separate units: technology transfer, the NSF I-Corps site, student and faculty innovation programs including the Morris L. Hayhurst Launch Lab, and assorted startup support services. It provides intellectual property and licensing services, prototyping and funding resources, and industry partnership development. The office is located in the WVU Innovation Corporation building on the former Mylan/Viatris site and includes federally funded energy incubator space available to startups across the state. Outside companies engage it as licensees, industry research partners and tenants of its incubator space.

Yale CBIT was established in 2014 to educate the next generation of biomedical innovators and support commercialization of biomedical technology discovered at Yale, with an explicit focus on data science, diagnostics and devices. It offers clinicians, students and faculty a structured pathway from idea submission through mentorship, funding opportunities and courses, and it runs a Leadership Innovation Fellowship for clinical innovators. Events such as Clinical Pitch Night connect Yale New Haven Hospital clinicians with engineers, designers and investors, and the CBIT Mentors program pairs teams with experienced advisors. The center is co-directed by a biomedical engineering professor and a practicing neurosurgeon who is also Vice President of Surgical Services at Yale New Haven Hospital, and it operates under the Yale Ventures umbrella.

Yale New Haven Hospital's nursing innovation work is organized around its Nursing Research and Evidence-Based Practice Committee, which supports teams of nurses running research and practice-change projects and helps them disseminate results at conferences and in peer-reviewed journals. The committee co-hosts the annual Janet Parkosewich Nursing Research and Evidence-Based Practice Conference with the Yale School of Nursing, where scholarly work is showcased and research awards are distributed. YNHH nurse executives have also been selected into the Johnson & Johnson Nurse Innovation Fellowship, receiving human-centered design mentorship to solve clinical problems identified at the point of service. Yale New Haven Health additionally operates a system-level Center for Health Care Innovation. Nursing leadership at the hospital is held by the senior vice president and chief nursing officer.

Yale Ventures is Yale University's innovation and commercialization organization, serving as the technology transfer office and the hub for faculty and student venture creation. It licenses Yale technologies, supports research spinouts, and provides translational funding and mentorship to move inventions toward market. Yale Ventures maintains a large portfolio of technologies available for licensing and runs programming to connect Yale inventors with investors and industry. Much of its portfolio is biomedical, drawing on Yale School of Medicine research.